Left bundle-branch block

I9_LBBB

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — I44.4, I44.5, I44.6, I44.7 Hospital discharge: ICD-9 — 426[2-3] Cause of death: ICD-10 — I44.4, I44.5, I44.6, I44.7 Cause of death: ICD-9 — 426[2-3] 2 out of 7 registries used, show all original rules.	3124
4. Check minimum number of events None	3124
5. Include endpoints None	3124
6. Filter based on genotype QC (FinnGen only)	3046

Control definitions (FinnGen only)

Control exclude: I9_OTHHEART

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2

NAME	I9_LBBB
CONTROL_EXCLUDE	I9_OTHHEART
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	I44[4-7]
HD_ICD_9	426[2-3]
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	I44[4-7]
COD_ICD_9	426[2-3]
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Left bundle-branch block based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17107	8747	8259
Only index persons	14924	7794	7130
Unadjusted period prevalence (%)
Whole population	0.24	0.25	0.23
Only index persons	0.28	0.29	0.27
Median age at first event (years)
Whole population	69.91	70.38	69.35
Only index persons	69.06	69.43	68.66

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3046	1515	1531
Unadjusted period prevalence (%)	0.62	0.54	0.70
Median age at first event (years)	68.66	67.40	69.90

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3124: Matched controls
31237

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

I48.1

ICD-10 Finland

Persistent atrial fibrillation

153.2

321.7

160

C01BD01

ATC

amiodarone; systemic

136.8

310.7

156

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3126.1

310.4

295

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

58.1

307.7

276

C03DA01

ATC

spironolactone; oral

9.0

307.7

813

1175

I44.0

ICD-10 Finland

Atrioventricular block, first degree

60.4

307.7

193

I44.4

ICD-10 Finland

Left anterior fascicular block

876.5

307.7

316

I44.7

ICD-10 Finland

Left bundle-branch block, unspecified

6713.1

307.7

2617

I48

ICD-10 Finland

Atrial fibrillation and flutter

109.4

307.7

927

120

I35.0

ICD-10 Finland

Aortic (valve) stenosis

37.8

307.7

286

B01AF02

ATC

apixaban; oral

11.0

307.7

530

572

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

594.5

307.7

581

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

98.9

307.7

263

I49.3

ICD-10 Finland

Ventricular premature depolarization

14.2

307.7

314

244

C03CA01

ATC

furosemide; systemic

4.7

307.7

1427

4704

C01AA05

ATC

digoxin; systemic

18.7

307.7

329

195

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

157.7

307.7

220

XF404

NOMESCO Finland

Ambulatory ECG

12.8

307.7

481

437

I42.0

ICD-10 Finland

Dilated cardiomyopathy

+∞

307.7

534

B01AA03

ATC

warfarin; systemic

6.1

307.7

724

1479

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

15.0

307.7

1687

2264

C07AB07

ATC

bisoprolol; oral

5.8

307.7

2144

8598

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

431.6

307.7

703

I50.9

ICD-10 Finland

Heart failure, unspecified

102.6

307.7

1016

146

201

Kela drug reimbursment

Chronic cardiac insufficiency

37.8

307.7

546

174

TFP20

NOMESCO Finland

Cardiodefibrillation

178.0

307.7

276

250, ,

Kela drug reimbursment

171.9

307.7

163

I50.1

ICD-10 Finland

Left ventricular failure

2678.1

307.7

676

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

500.1

307.7

758

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

+∞

307.7

648

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

136.0

307.7

318

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

7.3

307.7

1417

3182

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

479.6

307.7

382

I50.0

ICD-10 Finland

Congestive heart failure

186.8

307.7

462

207

Kela drug reimbursment

Chronic arrhythmias

389.7

307.7

697

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

9.1

307.7

1132

1843

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

10.7

307.7

606

688

I50

ICD-10 Finland

Heart failure

35.6

307.3

194

K78

ICPC

Atrial fibrillation/flutter

17.7

293.6

244

149

GD1LA

NOMESCO Finland

117.5

265.0

135

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

668.0

253.1

247

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

104.3

252.0

130

I44.2

ICD-10 Finland

Atrioventricular block, complete

2431.0

247.0

236

C09AA05

ATC

ramipril; oral

3.5

241.8

1226

4827

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

126.9

241.2

122

XF640, ,

NOMESCO Finland

15.8

230.5

202

136

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

8.8

228.6

301

374

AN1

Coronary angiography

4.8

226.8

584

1415

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

91.8

219.6

115

I47.1

ICD-10 Finland

Supraventricular tachycardia

34.6

214.3

136

I25.1

ICD-10 Finland

Atherosclerotic heart disease

3.5

213.1

1015

3796

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

3.3

208.3

1138

4619

I48.2

ICD-10 Finland

Chronic atrial fibrillation

433.3

205.8

204

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.1

203.5

1778

9399

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

55.3

197.5

112

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

5.7

192.9

390

762

I44.6

ICD-10 Finland

Other and unspecified fascicular block

908.2

176.9

172

R06.0

ICD-10 Finland

Dyspnoea

3.1

174.8

1049

4425

K77

ICPC

Heart failure

23.5

163.3

118

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

154.5

147

I49.5

ICD-10 Finland

Sick sinus syndrome

187.3

154.2

160

R07.4

ICD-10 Finland

Chest pain, unspecified

2.7

145.4

1110

5238

C09DX04

ATC

valsartan and sacubitril; oral

+∞

138.6

132

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

+∞

134.3

128

C01DA14

ATC

isosorbide mononitrate; oral

3.1

132.1

674

2545

I34.1

ICD-10 Finland

Mitral (valve) prolapse

54.1

129.9

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

+∞

129.0

123

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

128.9

629

2312

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

5.9

128.1

240

433

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

35.9

122.7

I47.2

ICD-10 Finland

Ventricular tachycardia

216.9

121.6

125

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

+∞

120.6

115

XF402

NOMESCO Finland

ECG with work load test

3.6

114.6

428

1328

I44.1

ICD-10 Finland

Atrioventricular block, second degree

139.8

113.9

121

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

21.6

109.7

TFP34

NOMESCO Finland

Electrophysiological investigation

286.1

108.7

110

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

9.0

106.5

133

153

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

37.4

106.4

A10BK01

ATC

dapagliflozin; oral

3.8

99.3

328

934

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

4.8

95.7

228

507

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

3.3

92.6

396

1330

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

322.3

92.4

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

91.1

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

903.9

90.2

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

+∞

90.0

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

117.1

84.4

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

2.4

81.6

670

3152

FN1AD

NOMESCO Finland

CT of coronary arteries

8.8

81.6

103

120

C01BC04

ATC

flecainide; systemic

39.1

81.4

FME20

NOMESCO Finland

Transvenous aortic valve replacement via femoral artery

+∞

79.5

R00.1

ICD-10 Finland

Bradycardia, unspecified

6.9

78.2

122

182

R55

ICD-10 Finland

Syncope and collapse

2.8

76.7

441

1742

I45.0

ICD-10 Finland

Right fascicular block

25.0

76.6

XF400

NOMESCO Finland

ECG with 12 standard connections

2.5

74.4

557

2502

C07AA07

ATC

sotalol; systemic

6.6

74.3

122

192

I10

ICD-10 Finland

Essential (primary) hypertension

2.1

74.2

2107

15697

I49.1

ICD-10 Finland

Atrial premature depolarization

8.2

73.9

124

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.7

72.4

242

691

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

4.7

71.6

172

384

C10AA05

ATC

atorvastatin; oral

2.0

71.6

1481

9848

AS4

Physiological pacemaker insertion DDD (R)

714.2

71.4

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

3.4

71.1

278

879

FPE25

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, atrial and ventricular electrodes, CRT-P (DDDR)

+∞

71.1

I45.3

ICD-10 Finland

Trifascicular block

360.3

70.9

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

7.2

67.9

102

146

K80

ICPC

Cardiac arrhythmia NOS

3.6

67.8

237

697

K84

ICPC

Heart disease other

6.4

67.4

114

185

Angiography of the heart and coronary arteries

3.5

67.1

243

731

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

15.0

66.5

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

5.5

64.7

127

238

I25.2

ICD-10 Finland

Old myocardial infarction

3.4

64.6

253

800

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

9.9

64.4

WX892

NOMESCO Finland

Monitored bed care

3.3

64.0

260

841

B01AF03

ATC

edoxaban; oral

14.5

63.1

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

4.4

61.5

159

376

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

5.3

60.3

125

246

A10BK03

ATC

empagliflozin; oral

2.6

58.1

362

1479

I20.99

ICD-10 Finland

Angina pectoris, unspecified

3.2

58.1

250

836

AP1

Catheterization of the left side of the heart

7.4

55.6

112

4263A

ICD-9 Finland

Conduction disorders, Other left bundle branch block

+∞

54.3

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

2.0

54.0

688

3797

B01AC04

ATC

clopidogrel; oral

2.1

53.6

594

3112

M04AA01

ATC

allopurinol; systemic

2.3

53.5

445

2074

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

6.9

53.5

123

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

3.8

53.0

169

466

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

14.3

52.8

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

+∞

52.2

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

+∞

52.2

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

3.2

51.7

212

688

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

+∞

51.2

I20.09

ICD-10 Finland

Unstable angina

3.2

50.8

210

685

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.1

50.7

594

3171

C07AB02

ATC

metoprolol; systemic

2.0

50.3

640

3521

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.8

49.7

266

1003

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

+∞

49.1

XFE00

NOMESCO Finland

Epicardial ultrasonography

6.5

48.7

126

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

+∞

48.0

B01AE07

ATC

dabigatran etexilate; oral

5.0

47.9

104

213

R02

ICPC

Shortness of breath/dyspnoea

2.3

47.5

396

1843

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

+∞

47.0

B01AF01

ATC

rivaroxaban; oral

2.3

46.4

376

1728

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

75.6

46.1

I45.2

ICD-10 Finland

Bifascicular block

75.6

46.1

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

+∞

45.9

ZXD05

NOMESCO Finland

Urgent procedure

1.8

45.6

863

5391

PD5AD

NOMESCO Finland

CT of aorta

5.8

45.2

146

H02AB06

ATC

prednisolone; systemic

1.7

45.1

1428

10323

I44.5

ICD-10 Finland

Left posterior fascicular block

+∞

44.9

WX872

NOMESCO Finland

Intensive care

3.6

44.5

153

444

I45.1

ICD-10 Finland

Other and unspecified right bundle-branch block

16.0

44.3

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

433.5

43.3

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

+∞

41.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

41.0

320

1444

I42.8

ICD-10 Finland

Other cardiomyopathies

+∞

40.7

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.9

40.5

197

704

M10.9

ICD-10 Finland

Gout, unspecified

2.7

40.4

227

876

I11

ICD-10 Finland

Hypertensive heart disease

13.3

40.0

I45.9

ICD-10 Finland

Conduction disorder, unspecified

76.2

40.0

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

39.8

361

1734

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

2.7

39.5

220

845

I44.3

ICD-10 Finland

Other and unspecified atrioventricular block

+∞

38.6

A02BC02

ATC

pantoprazole; systemic

1.7

38.1

2041

16596

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

197.4

37.9

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

5.0

37.8

168

AQ1

Conventional electrophysiological examination

+∞

37.6

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

36.9

243

1014

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

192.3

36.8

Z2221

NOMESCO Finland

Medical doctor

1.7

36.7

790

5074

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

+∞

36.5

J01DB01

ATC

cefalexin; oral

1.7

36.5

2399

20455

R53

ICD-10 Finland

Malaise and fatigue

1.8

36.2

664

4070

R03AC02

ATC

salbutamol; inhalant

1.6

36.1

1495

11346

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

+∞

35.5

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

3.0

35.4

160

549

N02BE01

ATC

paracetamol; systemic, rectal

1.9

35.3

2677

23653

ZXE00

NOMESCO Finland

One hour or less

1.6

35.2

1108

7854

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

35.1

776

5013

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

4.1

34.2

233

R00.2

ICD-10 Finland

Palpitations

2.7

34.2

186

706

C10AA01

ATC

simvastatin; oral

1.6

33.9

1425

10801

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

+∞

33.4

J01CA04

ATC

amoxicillin; systemic

1.7

33.3

2280

19347

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

33.0

342

1726

K99

ICPC

Cardiovascular disease other

4.3

32.9

201

TFP35

NOMESCO Finland

Electroanatomical mapping

118.0

32.7

I20.00

ICD-10 Finland

Unstable angina

3.7

32.6

106

296

K83

ICPC

Heart valve disease NOS

37.8

32.5

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

+∞

32.3

SPAT1097

SPAT

Recording of ECG

1.9

32.0

441

2463

FM1DE, ,

SPAT

36.8

31.5

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

+∞

31.3

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

+∞

31.3

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

+∞

31.3

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

6.5

30.7

XF409

NOMESCO Finland

Other special ECG

35.9

30.6

I20.90

ICD-10 Finland

Angina pectoris, unspecified

3.2

30.3

123

396

SPAT1263

SPAT

Sampling

1.6

29.8

1157

8536

E66.00

ICD-10 Finland

Metabolic syndrome

2.7

29.7

166

638

AA1AD

NOMESCO Finland

CT of head and brain

1.6

29.6

813

5521

I48.3

ICD-10 Finland

Typical atrial flutter

+∞

29.2

AS6

Biventricular physiological heart failure pacemaker insertion DDD (R)

+∞

29.2

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

+∞

29.2

C09CA03

ATC

valsartan; oral

2.1

29.2

308

1563

R07.3

ICD-10 Finland

Other chest pain

2.1

29.2

298

1494

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

29.1

600

3778

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

28.8

862

5972

M10

ICD-10 Finland

Gout

2.8

28.8

150

556

C08CA01

ATC

amlodipine; oral

1.5

28.6

1203

9012

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

28.3

331

1743

I42

ICD-10 Finland

Cardiomyopathy

+∞

28.2

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

+∞

28.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

28.0

744

5000

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

6.5

27.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

27.6

1051

7685

G47.3

ICD-10 Finland

Sleep apnoea

1.7

27.6

599

3818

C07AG02

ATC

carvedilol; oral

2.4

27.3

191

818

AB2

AVR bio, stent

+∞

27.1

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

26.4

800

5540

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

+∞

26.1

WX722

NOMESCO Finland

PEEP

2.8

25.9

136

506

C10AX09

ATC

ezetimibe; oral

1.8

25.8

468

2833

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

136.1

25.6

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.7

25.3

500

3101

C08DA01

ATC

verapamil; systemic

3.3

25.1

288

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.7

25.1

138

526

I48.4

ICD-10 Finland

Atypical atrial flutter

+∞

25.0

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

+∞

25.0

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

24.9

158

647

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

252.1

24.7

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

5.9

24.5

S18

ICPC

Laceration/cut

1.5

24.4

1346

10566

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

24.3

1093

8229

N19

ICD-10 Finland

Unspecified kidney failure

3.0

24.2

111

384

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

24.1

1352

10639

R42

ICD-10 Finland

Dizziness and giddiness

1.6

23.7

668

4530

Electrophysiological Special Examination

241.8

23.7

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

241.8

23.7

R00.0

ICD-10 Finland

Tachycardia, unspecified

3.1

23.0

315

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

23.0

486

3064

FXZ00

NOMESCO Finland

Off-pump cardiac operation

9.1

23.0

Initial pacemaker installation

+∞

22.9

R04.0

ICD-10 Finland

Epistaxis

2.2

22.8

212

1023

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

22.8

747

5242

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

22.6

152

639

M79.6

ICD-10 Finland

Pain in limb

1.5

22.5

1127

8640

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

22.4

375

2212

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

22.3

1085

8267

A98

ICPC

Health maint/preventive medicine

1.9

22.2

2844

26370

FN1BB

NOMESCO Finland

Contrast angiography of heart and/or coronary arteries after bypass surgery

7.3

22.0

42798

ICD-8 Finland

Symptomatic heart disease, Alia arrhytmia definita

+∞

21.9

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

2.1

21.5

206

1006

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

21.3

592

3990

C03AA03

ATC

hydrochlorothiazide; oral

1.9

21.2

282

1548

Q23.11

ICD-10 Finland

Bicuspid aortic valve

50.4

21.1

T90

ICPC

Diabetes non-insulin dependent

1.5

21.0

720

5088

M10.0

ICD-10 Finland

Idiopathic gout

2.8

21.0

105

381

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

21.0

306

1729

C09AA04

ATC

perindopril; oral

2.3

20.9

169

771

Z71.8

ICD-10 Finland

Other specified counselling

1.5

20.9

759

5434

AP4

Myocardial biopsy

+∞

20.9

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

+∞

20.9

Z13.6

ICD-10 Finland

Special screening examination for cardiovascular disorders

6.7

20.8

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

20.4

354

2108

WX110

NOMESCO Finland

Infiltration anesthesia

1.4

20.3

1896

16197

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.8

20.1

309

1775

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

+∞

19.8

A11

ICPC

Chest pain NOS

2.0

19.8

233

1227

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.5

19.7

705

5019

FL1AC

NOMESCO Finland

Left cardioangiography

4.3

19.7

121

J01MA12

ATC

levofloxacin; systemic

1.6

19.6

530

3545

A46

ICD-10 Finland

Erysipelas

1.7

19.4

393

2443

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

19.4

1065

8252

I20.0

ICD-10 Finland

Unstable angina

5.5

19.3

Z01.7

ICD-10 Finland

Laboratory examination

1.7

19.1

388

2412

C10AA07

ATC

rosuvastatin; oral

1.5

19.0

917

6925

R01.1

ICD-10 Finland

Cardiac murmur, unspecified

3.4

19.0

198

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.6

19.0

115

461

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

18.9

731

5284

ZYC01

NOMESCO Finland

Remote contact by phone

2.3

18.8

150

680

FPJ00

NOMESCO Finland

Revision of pacemaker pulse generator or electrode

+∞

18.8

JN3AD

NOMESCO Finland

Abdominal CT examination

1.8

18.7

312

1835

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

18.6

413

2627

K05

ICPC

Irregular heartbeat other

3.3

18.6

216

1CX08, ,

NOMESCO Finland

38.6

18.5

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

18.5

295

1713

C09AA02

ATC

enalapril; systemic

1.5

18.4

577

3987

FM1LE

NOMESCO Finland

Combined ultrasound and EKG examination of heart with tolerance test

7.5

18.2

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

18.2

169

816

PD5BD

NOMESCO Finland

Extensive CT of aorta

4.0

18.1

125

SPAT1325

SPAT

Vaccination

1.4

18.0

975

7508

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.3

17.9

136

605

I20.80

ICD-10 Finland

Other angina pectoris no detected stenosis of coronary artery

4.1

17.8

122

I51.4

ICD-10 Finland

Myocarditis, unspecified

+∞

17.7

I44

ICD-10 Finland

Atrioventricular and left bundle-branch block

+∞

17.7

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

+∞

17.7

Z3231

NOMESCO Finland

Registered nurse

1.5

17.7

745

5468

205

Kela drug reimbursment

Chronic hypertension

1.5

17.7

827

6195

TFJ02

NOMESCO Finland

Muscle biopsy of heart

181.0

17.5

R60.0

ICD-10 Finland

Localized oedema

1.7

17.4

344

2121

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

17.1

466

3112

UJF32

NOMESCO Finland

Coloscopy

1.5

17.0

737

5432

XCK10

NOMESCO Finland

Photography of fundus of eye

1.8

17.0

289

1707

L17

ICPC

Foot/toe symptom/complaint

1.5

17.0

772

5743

R4110

NOMESCO Finland

Physiotherapy

1.5

17.0

751

5558

R06.2

ICD-10 Finland

Wheezing

2.4

16.9

114

481

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

16.8

1013

7932

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

4.1

16.8

110

R05

ICD-10 Finland

Cough

1.5

16.8

569

3991

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.5

16.7

105

429

L28

ICPC

Limited function/disability (L)

1.5

16.5

523

3613

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.7

16.4

332

M54.5

ICD-10 Finland

Low back pain

1.4

16.4

886

6801

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

16.3

1040

8210

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

16.3

894

6880

A12BA01

ATC

potassium chloride; oral

2.4

16.2

110

465

J01FF01

ATC

clindamycin; systemic

1.5

16.2

693

5092

WZC30

NOMESCO Finland

Teaching

1.6

16.1

435

2899

E66.01

ICD-10 Finland

Obesity due to excess calories

2.0

16.1

175

896

FM1TQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT at rest and with exercise

16.8

16.1

K04

ICPC

Palpitations/awareness of heart

2.5

16.0

105

437

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

16.0

182

946

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

47.7

16.0

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

15.9

239

1363

A10BA02

ATC

metformin; oral

1.4

15.7

814

6190

C08CA13

ATC

lercanidipine; oral

1.6

15.7

413

2733

E87.5

ICD-10 Finland

Hyperkalaemia

3.6

15.7

148

R03BB04

ATC

tiotropium bromide; inhalant

1.7

15.7

289

1747

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

+∞

15.6

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

15.6

764

5752

AS2

Ventricular pacemaker insertion VVI (R)

160.8

15.5

ZXD00

NOMESCO Finland

Emergency procedure

2.7

15.4

314

B01AB05

ATC

enoxaparin; parenteral

1.4

15.4

854

6572

C09CA06

ATC

candesartan; oral

1.5

15.4

630

4584

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

15.4

143

691

J01AA02

ATC

doxycycline; systemic

1.4

15.3

2229

20008

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.5

15.3

555

3943

SPAT1310

SPAT

Counselling related to known health issue

1.4

15.1

835

6415

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.2

15.1

135

642

FM3CN

NOMESCO Finland

Heart perfusion isotope imaging both at rest and with exercise

20.1

15.1

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.9

14.7

194

1061

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.5

14.6

436

2967

J20

ICD-10 Finland

Acute bronchitis

1.7

14.6

256

1525

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

14.6

970

7681

Initial installation of the atrial pacemaker

+∞

14.6

H25.8

ICD-10 Finland

Other senile cataract

1.6

14.5

371

2439

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

150.7

14.5

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

14.4

674

5020

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

14.4

152

771

E0000UV, ,

ATC

1.4

14.3

1075

8672

SPAT1104

SPAT

Monitoring of emergency patient

2.0

14.3

166

870

XG466

NOMESCO Finland

Sleep oxymetry

2.7

14.3

292

4130X

ICD-9 Finland

Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]

3.4

14.2

148

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

14.2

393

2630

I21.40

ICD-10 Finland

Acute subendocardial infarction no detected stenosis of the coronary artery

2.8

14.2

259

WX002

NOMESCO Finland

Sedation and analgesia

1.5

14.0

534

3822

A08

ICPC

Swelling

2.1

14.0

141

702

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

2.1

13.9

130

630

AP2

Catheterization of the right side of the heart

30.2

13.9

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

30.2

13.9

R01AD09

ATC

mometasone; nasal

1.4

13.8

1078

8740

WX730

NOMESCO Finland

Conventional respirator

3.9

13.8

104

I20.01

ICD-10 Finland

Unstable angina

2.5

13.8

327

I21.99

ICD-10 Finland

Myocardial infarction (acute) UNS unspecified coronary artery status

2.7

13.7

287

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

6.5

13.6

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.1

13.6

125

602

R04.2

ICD-10 Finland

Haemoptysis

2.3

13.6

101

446

SPAT1153

SPAT

Removal of sutures

1.4

13.6

903

7136

FPJ12

NOMESCO Finland

Revision of biventricular CRT-P (DDDR) generator

+∞

13.5

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

+∞

13.5

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

13.5

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

+∞

13.5

342

Kela drug reimbursment

Dronedarone

+∞

13.5

E66.9

ICD-10 Finland

Obesity, unspecified

2.6

13.5

306

C09CA01

ATC

losartan; oral

1.4

13.5

718

5463

GD2SN

NOMESCO Finland

Lung ventilation SPECT

5.9

13.5

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

140.6

13.5

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

140.6

13.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

13.4

494

3513

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

13.3

1137

9328

SPAT1312

SPAT

General health counselling

1.4

13.3

789

6112

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

2.9

13.3

212

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

13.3

500

3568

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

13.3

171

928

A04

ICPC

Weakness/tiredness general

1.6

13.3

348

2299

I20.9

ICD-10 Finland

Angina pectoris, unspecified

3.6

13.2

121

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

13.2

290

1834

SPAT1262

SPAT

Handing over of treatment supplies

1.5

13.2

486

3452

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

13.1

774

5992

J01DA01

ATC

[U] cefalexin

1.3

13.1

1660

14409

N02AX02

ATC

tramadol; systemic, rectal

1.3

13.1

1166

9623

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.9

13.0

SPAT1254

SPAT

Administration of medicine

1.5

13.0

376

2540

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

13.0

655

4937

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

12.9

349

2321

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

12.8

462

3267

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.2

12.8

107

496

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

12.7

1739

15228

A10BH05

ATC

linagliptin; oral

2.0

12.6

142

737

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

12.6

357

2399

FM1AT

NOMESCO Finland

Percutaneous implantation of aortic valve endoprosthesis

+∞

12.5

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

+∞

12.5

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

+∞

12.5

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

+∞

12.5

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

+∞

12.5

FPJ

NOMESCO Finland

Review and replacement of pacemaker or internal defibrillator device or electrode

+∞

12.5

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

+∞

12.5

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

+∞

12.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

12.5

848

6706

WZA90

NOMESCO Finland

Other medical or dental certificate

1.4

12.5

563

4156

C01BA03

ATC

disopyramide; systemic

24.4

12.5

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

12.3

205

1205

K02.1

ICD-10 Finland

Caries of dentine

1.3

12.2

1398

11917

H02AB07

ATC

prednisone; oral

1.5

12.2

366

2490

I95.2

ICD-10 Finland

Hypotension due to drugs

4.8

12.1

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

12.1

141

741

N30.0

ICD-10 Finland

Acute cystitis

1.5

12.1

392

2712

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.4

11.9

332

I49

ICD-10 Finland

Other cardiac arrhythmias

3.8

11.9

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

11.9

472

3399

Z01.2

ICD-10 Finland

Dental examination

1.3

11.9

1069

8802

C08DB01

ATC

diltiazem; oral

2.0

11.8

133

690

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

14.7

11.8

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

11.7

217

FM1EE, ,

SPAT

4.0

11.6

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

23.0

11.6

A10AB05

ATC

insulin aspart; parenteral

1.8

11.5

179

1030

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

3.7

11.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

11.5

388

FMD22

NOMESCO Finland

Percutaneous transluminal replacement of aortic valve using biological prosthesis

+∞

11.5

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

+∞

11.5

C01BD07

ATC

dronedarone; oral

+∞

11.5

4289X

ICD-9 Finland

Heart failure, unspecified

+∞

11.5

AQ2

Electrophysiological electroanatomical examination

+∞

11.5

AR5

Catheter ablation of arrhythmia, target: atrial flutter

120.4

11.4

FN2AB

NOMESCO Finland

Percutaneous transluminal coronary angioplasty (PTCA), drug-eluting balloon

3.0

11.4

170

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

11.4

142

763

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.9

11.4

181

R03BA02

ATC

budesonide; inhalant

1.5

11.3

420

2984

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

11.3

327

2207

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.8

11.3

204

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

11.2

251

1595

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

11.2

137

732

R94.3

ICD-10 Finland

Abnormal results of cardiovascular function studies

4.0

11.2

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

17.1

11.2

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

11.2

139

747

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

11.1

112

559

H26.4

ICD-10 Finland

After-cataract

1.6

11.0

302

2012

A10AE04

ATC

insulin glargine; parenteral

1.6

11.0

232

1453

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

10.1

11.0

FM1CR

NOMESCO Finland

Heart perfusion PET with TT

9.2

11.0

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.4

10.9

516

3831

AP3

Catheterization of the right and left side of the heart

43.5

10.9

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

2.1

10.9

469

C10AA03

ATC

pravastatin; oral

1.7

10.9

204

1239

N03AX16

ATC

[U] pregabalin

1.4

10.8

598

4565

I21.90

ICD-10 Finland

Myocardial infarction (acute) UNS no detected stenosis of the coronary artery

3.0

10.7

160

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.7

10.7

214

1322

SPAT1211

SPAT

Application of soft bandage

1.6

10.7

226

1416

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

10.7

161

919

R31

ICD-10 Finland

Unspecified haematuria

1.6

10.7

272

1783

S97

ICPC

Chronic ulcer skin

1.8

10.6

147

819

E66.0

ICD-10 Finland

Obesity due to excess calories

4.2

10.5

J45

ICD-10 Finland

Asthma

1.6

10.5

227

1432

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

10.4

343

2377

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

+∞

10.4

42700

ICD-8 Finland

Symptomatic heart disease, Congestive heart failure

+∞

10.4

4276B

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA VENTRICULARIS]

+∞

10.4

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

+∞

10.4

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

+∞

10.4

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

+∞

10.4

WX930

NOMESCO Finland

Thepapeutic hypothermia

+∞

10.4

AC4

MVP

+∞

10.4

K30

ICD-10 Finland

Functional dyspepsia

1.6

10.3

263

1724

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.9

10.3

169

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

10.3

471

3475

R2110

NOMESCO Finland

Giving the first information

1.8

10.2

144

805

SPAT1260

SPAT

Consultation of another employee

1.4

10.2

431

3135

R07.2

ICD-10 Finland

Precordial pain

2.6

10.2

233

K29

ICPC

Cardiovascular sympt/complt other

2.0

10.2

107

543

AA1

Conventional CABG

2.9

10.2

165

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

10.1

136

750

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.4

10.1

651

5083

J01FA06

ATC

roxithromycin; oral

1.3

10.1

1012

8416

R52.9

ICD-10 Finland

Pain, unspecified

1.6

10.0

235

1510

TFC10

NOMESCO Finland

Catheterisation of left atrium or ventricle

3.2

10.0

124

FC1AC

NOMESCO Finland

Angiography of thoracal aortta

14.6

10.0

C02AC05

ATC

moxonidine; oral

1.9

10.0

115

603

N05CF01

ATC

zopiclone; oral

1.3

10.0

878

7171

N17.8

ICD-10 Finland

Other acute renal failure

3.7

10.0

I51.9

ICD-10 Finland

Heart disease, unspecified

40.2

10.0

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

9.9

1772

15828

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

7.6

9.9

R05

ICPC

Cough

1.4

9.9

574

4408

C08CA07

ATC

nisoldipine; oral

3.3

9.8

110

A10BH01

ATC

sitagliptin; oral

1.6

9.8

263

1744

C10AA04

ATC

fluvastatin; oral

1.6

9.8

246

1607

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

9.8

1113

9396

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.7

9.8

191

C07AB12

ATC

nebivolol; oral

2.3

9.8

324

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

9.8

176

1058

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.2

9.8

350

M25.5

ICD-10 Finland

Pain in joint

1.3

9.7

752

6029

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

9.7

114

602

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.8

9.7

130

717

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

9.7

397

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

13.4

9.7

WX740

NOMESCO Finland

Nitrogen oxide therapy

55.2

9.6

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

9.6

599

4649

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

2.5

9.6

228

ZYC03

NOMESCO Finland

Remote contact, text-based

4.6

9.5

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

9.5

1345

11659

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

9.5

1582

13982

A10BJ06

ATC

semaglutide; parenteral

1.9

9.4

116

622

FM2CQ

NOMESCO Finland

Heart perfusion SPECT with low dose CT with exercise

100.3

9.4

I45.5

ICD-10 Finland

Other specified heart block

100.3

9.4

N17

ICPC

Vertigo/dizziness

1.5

9.4

318

2217

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

+∞

9.4

PH3AC

NOMESCO Finland

Flebography of internal organs with X-ray

+∞

9.4

FA1AC

NOMESCO Finland

Upper cavography

+∞

9.4

I42.7

ICD-10 Finland

Cardiomyopathy due to drugs and other external agents

+∞

9.4

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

+∞

9.4

I46.9

ICD-10 Finland

Cardiac arrest, unspecified

+∞

9.4

AT4

Physiological pacemaker replacement DDD (R)

+∞

9.4

4254A

ICD-9 Finland

Cardiomyopathy, Other primary cardiomyopathies

+∞

9.4

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

+∞

9.4

I51.7

ICD-10 Finland

Cardiomegaly

+∞

9.4

4262A

ICD-9 Finland

Conduction disorders, Left bundle branch hemiblock

+∞

9.4

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

+∞

9.4

FP1B5, ,

SPAT

2.6

9.4

213

UJF30

NOMESCO Finland

Ileoscopy through colon

1.6

9.3

251

1666

L03

ICPC

Low back symptom/complaint

1.3

9.3

651

5137

R06AE07

ATC

cetirizine; oral

1.3

9.3

1039

8740

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

9.2

473

SPAT1081

SPAT

Cardiorespiratory global assessment

1.8

9.2

138

788

TK800

NOMESCO Finland

Hemodialysis

2.7

9.2

169

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

9.2

116

628

R11

ICD-10 Finland

Nausea and vomiting

1.6

9.2

194

1217

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.2

321

2253

A02BC05

ATC

esomeprazole; systemic

1.3

9.1

1057

8930

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

9.0

459

3446

J81

ICD-10 Finland

Pulmonary oedema

9.0

R07.1

ICD-10 Finland

Chest pain on breathing

3.1

9.0

122

Z3226

NOMESCO Finland

Physiotherapist

1.4

9.0

454

3406

UKC02

NOMESCO Finland

Cystoscopy

1.4

8.9

459

3453

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

8.9

374

2716

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.4

8.9

237

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

8.9

197

1251

R03BA08

ATC

ciclesonide; inhalant

1.6

8.8

191

1204

K59.0

ICD-10 Finland

Constipation

1.7

8.8

155

926

GD1AD

NOMESCO Finland

Thorax CT examination

1.8

8.8

135

776

ANC

Coronary artery pressure measurement (FFR, fractional flow reserve)

4.0

8.8

XF405

NOMESCO Finland

Symptom ECG

7.2

8.7

C01BA01

ATC

quinidine; oral

14.1

8.7

I45.6

ICD-10 Finland

Pre-excitation syndrome

50.1

8.7

Z50.0

ICD-10 Finland

Cardiac rehabilitation

3.6

8.7

A10AC01

ATC

insulin (human); parenteral

1.7

8.7

168

1031

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

8.6

217

1419

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

8.6

123

692

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.5

8.6

244

1640

A41.8

ICD-10 Finland

Other specified sepsis

2.6

8.6

193

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

8.5

390

2874

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

1.7

8.5

162

989

Z94.1

ICD-10 Finland

Heart transplant status

27.6

8.5

3A064, ,

NOMESCO Finland

27.6

8.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

8.5

209

1361

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

2.8

8.4

154

J01FA10

ATC

azithromycin; systemic

1.3

8.4

1329

11611

D07AC13

ATC

mometasone; topical

1.3

8.4

724

5878

C01BC03

ATC

propafenone; systemic

+∞

8.3

4260A

ICD-9 Finland

Conduction disorders, Atrioventricular block, complete

+∞

8.3

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

+∞

8.3

4278X

ICD-9 Finland

Cardiac dysrhythmias, Other specified cardiac dysrhythmias[DYSRHYTMIAE CORDIS ALIA DEFINITA]

+∞

8.3

Catheter ablation of arrhythmia

+∞

8.3

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

+∞

8.3

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

8.3

401

2982

ZYC01, ,

SPAT

1.6

8.3

192

1231

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.0

8.3

422

R03BA05

ATC

fluticasone; inhalant

1.4

8.3

398

2958

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

8.3

1023

8685

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.1

8.3

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

2.9

8.2

134

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

8.2

323

H02AB04

ATC

methylprednisolone; systemic

1.4

8.2

344

2498

I20.8

ICD-10 Finland

Other forms of angina pectoris

3.7

8.2

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

8.1

286

2009

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

8.1

299

2119

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

8.1

510

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

33.4

8.1

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

8.0

129

752

R06

ICPC

Nose bleed/epistaxis

2.4

8.0

236

ZXA10

NOMESCO Finland

Bilateral

1.3

8.0

490

3784

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

22.1

8.0

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

8.0

337

2447

Single vessel balloon catheter extension

2.3

8.0

249

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

8.0

122

701

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

8.0

1168

10098

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

8.0

1103

9477

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.0

1375

12108

U07

ICPC

Urine symptom/complaint other

1.6

7.9

195

1271

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

7.9

166

1042

K57

ICD-10 Finland

Diverticular disease of intestine

2.2

7.8

283

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.8

7.8

109

609

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.8

7.8

104

573

XKD00

NOMESCO Finland

Uroflowmetry

1.4

7.8

459

3523

M01AE02

ATC

naproxen; oral, rectal

1.2

7.8

1416

12528

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

7.8

923

7786

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

7.8

273

1917

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.4

7.7

203

WX320

NOMESCO Finland

Spinalanesthesy

1.3

7.7

652

5269

AB1

AVR mechanical

45.1

7.7

Z00.0

ICD-10 Finland

General medical examination

1.3

7.7

473

3654

GD1UN

NOMESCO Finland

Lung circulation SPECT

6.4

7.7

127

Kela drug reimbursment

Transplant complication

3.1

7.7

101

R03BA01

ATC

beclometasone; inhalant

1.4

7.7

329

2396

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

7.7

161

1009

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

7.7

640

5164

A28

ICPC

Limited function/disability NOS

1.3

7.7

475

3675

SPAT1229

SPAT

Assessment of need for aid

1.5

7.7

202

1336

C07AB03

ATC

atenolol; systemic

1.7

7.7

139

839

R03DA04

ATC

theophylline; systemic, rectal

1.7

7.6

137

824

R35

ICD-10 Finland

Polyuria

1.6

7.6

182

1176

I95.1

ICD-10 Finland

Orthostatic hypotension

1.9

7.6

528

E05.89

ICD-10 Finland

Other thyrotoxicosis

18.4

7.6

I45.8

ICD-10 Finland

Other specified conduction disorders

18.4

7.6

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

7.5

341

2507

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

3.2

7.5

TGC00

NOMESCO Finland

Bronchial lavation

2.2

7.5

295

U72

ICPC

Urethritis

2.2

7.5

269

J01MA02

ATC

ciprofloxacin; systemic

1.2

7.5

1037

8893

SPAT1276

SPAT

Outlining of treatment with patient or their family members

2.2

7.5

289

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

7.5

383

C08CA02

ATC

felodipine; oral

1.5

7.4

245

1701

E000001, ,

ATC

1.3

7.4

451

3482

A11CC03

ATC

alfacalcidol; systemic

2.4

7.3

196

A10BJ02

ATC

liraglutide; parenteral

2.2

7.3

285

M10.3

ICD-10 Finland

Gout due to impairment of renal function

8.4

7.3

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

7.3

242

1680

4241B

ICD-9 Finland

Other diseases of endocardium, Aortic valve disorders[STENOSIS VALVULAE AORTAE (NON RHEUMATICA)]

+∞

7.3

5273

FHL

Repair with flap prosthesis or graft

+∞

7.3

FPE10

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial electrode

+∞

7.3

I42.6

ICD-10 Finland

Alcoholic cardiomyopathy

+∞

7.3

FPF00

NOMESCO Finland

Implantation of epicardial pacemaker with ventricular electrode

+∞

7.3

ASX

Other pacemaker insertion

+∞

7.3

42728

ICD-8 Finland

Symptomatic heart disease, Dissociatio cordis alia

+∞

7.3

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.5

7.3

248

1731

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.9

7.3

110

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.9

7.3

110

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

7.3

363

2715

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

7.2

172

1111

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.1

7.2

293

D82

ICPC

Teeth/gum disease

1.3

7.2

793

6617

WZC30, ,

SPAT

1.7

7.2

133

808

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

2.0

7.2

389

M03BX02

ATC

tizanidine; oral

1.2

7.2

1521

13633

K01

ICPC

Heart pain

2.8

7.2

122

ZX120

NOMESCO Finland

Intravenous

1.5

7.2

218

1488

742, ,

NOMESCO Finland

30.1

7.1

K07

ICPC

Swollen ankles/oedema

1.8

7.1

103

583

E66.8

ICD-10 Finland

Other obesity

1.9

7.1

489

I21.97

ICD-10 Finland

Suspected acute myocardial infarction

3.4

7.1

R4110, ,

SPAT

1.5

7.1

221

1515

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

2.8

7.1

117

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

7.1

412

3155

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.0

7.1

101

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

2.9

7.0

112

M54

ICD-10 Finland

Dorsalgia

1.5

7.0

256

1810

SFA10

NOMESCO Finland

One-surface restoration

1.2

7.0

1289

11379

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.0

612

4965

A97

ICPC

No disease

1.3

7.0

435

3367

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

7.0

345

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

7.0

500

C09BA02

ATC

enalapril and diuretics; systemic

1.5

6.9

209

1426

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.2

6.9

253

R51.80

ICD-10 Finland

Headache

1.4

6.9

296

2159

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

6.9

277

1997

K24

ICPC

Fear of heart disease

2.1

6.9

313

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.5

6.8

160

C07AB05

ATC

betaxolol; oral

2.0

6.8

327

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

6.8

162

1047

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

6.8

475

3735

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

6.8

149

945

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.4

6.8

191

4029A

ICD-9 Finland

Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]

6.1

6.8

SPAT1281

SPAT

Other administrative function

1.5

6.7

181

1203

K64.0

ICD-10 Finland

First degree haemorrhoids

2.3

6.7

198

K28

ICPC

Limited function/disability (K)

2.2

6.7

262

AN4

Balloon angioplasty and drug eluding stent

1.9

6.7

413

D07AC01

ATC

betamethasone; topical

1.2

6.7

898

7659

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.9

6.6

421

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

1.4

6.6

250

1780

S22.3

ICD-10 Finland

Fracture of rib

1.5

6.6

172

1135

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

7.8

6.6

R03AC13

ATC

formoterol; inhalant

1.7

6.6

120

726

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.0

6.6

352

WZC00, ,

SPAT

1.5

6.6

217

1507

WX882

NOMESCO Finland

High dependency care

2.1

6.5

265

H81

ICPC

Excessive ear wax

1.3

6.5

480

3802

Coronary artery bypass surgery

2.3

6.5

201

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

6.5

358

2718

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.5

636

5226

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

6.5

174

1156

A02BC03

ATC

lansoprazole; oral

1.3

6.5

745

6238

SPAT1216

SPAT

Assessment of functional ability

1.3

6.5

423

3295

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.7

6.5

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.3

6.5

208

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.0

6.4

355

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.4

412

3199

Catheterization and pressure measurement of the left side of the heart

2.5

6.4

147

5401

FHL

Pacemaker installation, transvenous electrode

70.0

6.4

T82.1

ICD-10 Finland

Mechanical complication of cardiac electronic device

70.0

6.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.4

585

4766

C02EA02, ,

ATC

1.7

6.4

112

671

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

6.4

470

3722

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

6.4

235

1666

R23.3

ICD-10 Finland

Spontaneous ecchymoses

2.3

6.4

203

4019X

ICD-9 Finland

Essential hypertension, Unspecified

2.0

6.4

343

R50.9

ICD-10 Finland

Fever, unspecified

1.4

6.3

320

2397

K87

ICPC

Hypertension complicated

2.0

6.3

316

ZXH06, ,

SPAT

1.7

6.3

106

628

R5110, ,

SPAT

1.5

6.3

174

1164

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

6.3

730

6120

Z92.1

ICD-10 Finland

Personal history of long-term (current) use of anticoagulants

18.0

6.3

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

6.3

103

I41.8

ICD-10 Finland

Myocarditis in other diseases classified elsewhere

+∞

6.3

I45.4

ICD-10 Finland

Nonspecific intraventricular block

+∞

6.3

4270A

ICD-9 Finland

Cardiac dysrhythmias, Paroxysmal supraventricular tachycardia

+∞

6.3

4240A

ICD-9 Finland

Other diseases of endocardium, Mitral valve disorders[INSUFFICIENTIA VALVULAE MITRALIS (NON RHEUMATICA)]

+∞

6.3

4259X

ICD-9 Finland

Cardiomyopathy, Secondary cardiomyopathy, unspecified

+∞

6.3

TFP33

NOMESCO Finland

Simple electrophysiological investigation (e.g. ventricular stimulation)

+∞

6.3

FPJ11

NOMESCO Finland

Revision of biventricular CRT-P (VVIR) generator

+∞

6.3

XX3CW, ,

NOMESCO Finland

+∞

6.3

Aortic Valve Replacement (AVR)

+∞

6.3

4276A

ICD-9 Finland

Cardiac dysrhythmias, Premature beats[EXTRASYSTOLIA SUPRAVENTRICULARIS]

+∞

6.3

Mitral valve Replacement (MVR)

+∞

6.3

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

+∞

6.3

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

+∞

6.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

6.2

262

1902

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

26.7

6.2

I95

ICD-10 Finland

Hypotension

4.0

6.2

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.1

6.2

S01BC05

ATC

ketorolac; ophthalmic

1.7

6.2

103

610

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

6.1

647

5360

ZXA00

NOMESCO Finland

Right side

1.3

6.1

700

5853

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

6.1

433

R78

ICPC

Acute bronchitis/bronchiolitis

2.2

6.1

233

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.5

6.1

172

1157

WX290

NOMESCO Finland

Other blockage of nerve

1.2

6.1

957

8286

130

Kela drug reimbursment

Malignant tumour

0.6

6.1

131

2012

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.6

6.0

136

869

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

6.0

264

1931

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.3

6.0

435

3435

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

6.0

323

2442

7865A

ICD-9 Finland

Symptoms involving respiratory system and other chest symptoms, Chest pain

2.3

6.0

189

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

6.0

672

5603

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

6.0

981

8518

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

6.0

390

3035

N18.0

ICD-10 Finland

End-stage renal disease

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2018

5489

8.56

307.65

4.9

1.8

1597.38

551.72

ng/l

31.27

1821

4439

(3027456) Digoxin [Moles/volume] in Serum or Plasma

151

46.61

256.79

3.4

1.4

0.78

1.24

nmol/l

—

115

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1674

8392

3.14

213.88

5.4

2.8

51.65

122.19

ng/l

0.64

1316

5956

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

783

2655

3.60

189.09

2.5

2.2

22.26

23.75

2.09

696

2234

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

561

1519

4.28

187.01

3.1

1.8

272.99

87.09

ng/l

13.80

526

1350

(3004789) Transferrin [Mass/volume] in Serum or Plasma

813

2846

3.51

186.59

2.5

2.1

2.31

2.30

g/l

0.35

757

2597

(3022948) Iron [Moles/volume] in Serum or Plasma

851

3118

3.38

180.99

2.5

2.1

13.04

13.38

umol/l

0.60

802

2866

(3022217) INR in Platelet poor plasma by Coagulation assay

1803

10240

2.80

169.71

23.2

5.9

1.38

1.10

inr

21.27

472

2791

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

878

4002

2.66

119.56

5.0

2.8

498.08

378.56

ng/l

0.29

787

3135

(3013512) EKG study

1276

7189

2.31

106.84

6.4

3.2

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1437

8740

2.19

97.29

3.2

2.5

150.20

151.78

ug/l

0.08

1304

7911

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

206

450

4.83

88.26

2.4

1.7

10.60

11.23

mg/l

0.52

193

410

(3013826) Glucose [Moles/volume] in Serum or Plasma

1966

13972

2.10

83.40

5.5

3.8

6.83

6.77

mmol/l

0.73

1877

12987

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

279

810

3.68

81.65

2.2

1.6

34.31

39.36

u/l

3.21

214

719

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1001

5587

2.16

80.93

2.4

2.0

2.98

2.84

mg/l

0.87

846

4647

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

419

1644

2.79

73.62

2.4

1.9

9.37

5.59

ug/l

1.53

346

1372

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1625

11096

1.97

73.17

6.1

5.0

1.21

1.22

mmol/l

3.21

1469

9924

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2659

21843

2.46

70.72

5.4

4.5

1.97

2.13

mu/l

0.90

2386

19414

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

826

4519

2.13

68.45

2.1

1.6

1.30

1.38

mg/l

0.22

615

3533

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

680

3494

2.21

65.82

1.9

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1723

12406

1.87

61.89

5.8

6.2

12.05

11.45

umol/l

1.07

1627

11719

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2795

23891

2.61

61.10

19.8

12.6

22.81

26.15

mg/l

6.54

2353

18577

(3013115) Eosinophils [#/volume] in Blood

1653

11783

1.86

60.95

5.8

5.6

0.20

e9/l

0.66

1411

10119

(3006315) Basophils [#/volume] in Blood

1607

11397

1.84

59.81

5.6

5.4

0.04

e9/l

0.45

1364

9657

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1120

7095

1.90

59.67

2.2

2.0

202.84

210.49

u/l

0.10

1042

6582

(3019550) Sodium [Moles/volume] in Serum or Plasma

2926

25660

3.21

59.63

25.4

14.2

139.66

139.71

mmol/l

0.50

2866

24858

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1709

12361

1.84

59.59

6.9

5.6

1.21

1.22

mmol/l

3.42

1431

10418

(3001604) Monocytes [#/volume] in Blood

1600

11361

1.84

59.03

5.6

5.4

0.64

0.60

e9/l

5.39

1361

9622

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2701

22848

2.34

58.50

7.2

5.9

41.01

40.04

mmol/mol

6.64

2448

20744

(3023103) Potassium [Moles/volume] in Serum or Plasma

2928

25736

3.19

58.43

25.7

14.3

4.02

3.98

mmol/l

13.72

2864

24892

(3019198) Lymphocytes [#/volume] in Blood

1630

11674

1.83

58.14

5.8

5.5

1.84

1.96

e9/l

1.24

1406

10118

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2359

19043

1.97

56.74

7.8

7.2

77.84

79.73

u/l

1.24

2219

17735

(3006504) Eosinophils/100 leukocytes in Blood

1519

10706

1.81

56.57

6.0

5.7

2.90

2.93

0.21

1410

9835

(3019069) Monocytes/100 leukocytes in Blood

1524

10765

1.81

56.22

6.3

6.0

8.93

8.74

1.29

1416

9908

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2216

17565

1.90

55.75

4.3

3.8

15.13

14.86

pmol/l

4.93

1971

15550

(40760892) CBC W Ordered Manual Differential panel - Blood

1506

10656

1.80

54.73

6.2

6.0

—

(3023368) Bacteria identified in Blood by Culture

1009

6326

1.88

54.44

4.6

3.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

599

3151

2.11

53.46

2.3

1.8

30.25

28.79

8.35

584

3063

(3018010) Neutrophils/100 leukocytes in Blood

1522

10855

1.78

53.38

5.8

5.6

58.58

57.02

5.44

1418

10013

(3002030) Lymphocytes/100 leukocytes in Blood

1536

11021

1.77

52.43

6.1

5.8

25.85

27.88

9.96

1429

10166

(3022096) Basophils/100 leukocytes in Blood

1464

10383

1.77

51.82

6.0

5.7

0.67

0.68

0.46

1346

9525

(3012095) Magnesium [Moles/volume] in Serum or Plasma

630

3427

2.05

51.17

3.5

3.1

0.83

0.81

mmol/l

2.49

580

3172

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2699

23169

2.21

50.66

20.0

12.2

72.30

77.61

ml/min/173m2

32.26

2346

18770

(3020779) Urea [Moles/volume] in Serum or Plasma

385

1731

2.40

50.11

8.0

5.6

11.93

9.10

mmol/l

8.76

369

1638

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

170

504

3.51

47.83

2.7

2.4

0.36

0.35

u/ml

0.20

101

262

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

305

1266

2.56

47.07

4.2

2.9

1.58

1.61

mmol/l

0.05

236

915

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2657

22852

2.09

46.75

4.8

4.0

1.33

1.29

mmol/l

1.69

2386

20292

(3013707) Erythrocyte sedimentation rate by Westergren method

2207

17904

1.79

46.28

4.5

3.9

13.36

12.56

mm/h

1.72

1989

16314

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2798

24596

2.32

45.81

6.1

5.0

2.48

2.76

mmol/l

50.84

2540

22139

(3044640) Blood type and Crossmatch panel - Blood

1122

7585

1.75

45.24

2.6

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

312

1337

2.48

44.94

4.3

2.9

5.14

5.11

kpa

0.30

289

1256

(3013650) Neutrophils [#/volume] in Blood by Automated count

1760

13473

1.70

44.72

8.0

9.0

4.30

4.08

e9/l

3.45

1503

11631

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2724

23748

2.15

44.62

5.4

4.4

1.40

1.49

mmol/l

22.87

2462

21308

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2745

24005

2.18

44.54

5.7

4.7

6.14

6.00

mmol/l

6.81

2453

21440

(3009343) pH of Capillary blood

306

1319

2.46

43.48

4.3

2.9

7.42

0.40

142

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2891

25891

2.56

43.37

12.5

10.1

27.01

25.49

u/l

1.03

2770

24687

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

900

5777

1.78

43.01

2.5

2.3

—

(40761511) CBC panel - Blood by Automated count

2815

24944

2.30

42.88

19.7

12.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2734

23968

2.13

42.53

5.4

4.5

4.33

4.69

mmol/l

60.46

2492

21671

(3031040) Bacteria [#/volume] in Urine by Automated count

2001

16067

1.68

40.49

5.3

4.4

967.24

2499.18

e6/l

1.33

256

(3016502) Oxygen saturation in Arterial blood

413

2081

2.13

40.42

6.8

6.4

95.24

96.11

1.94

404

2003

(3027945) Reticulocytes/100 erythrocytes in Blood

475

2525

2.04

40.28

2.4

2.2

1.71

1.66

0.57

420

2179

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

255

1052

2.55

39.69

8.8

7.8

23.90

24.24

mmol/l

0.81

248

1024

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

580

3328

1.91

39.35

5.0

4.7

33.59

32.88

0.82

419

2051

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1437

10662

1.64

39.17

2.2

2.0

96.04

94.36

pmol/l

0.55

742

5368

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

467

2492

2.03

39.11

4.0

4.1

247.33

239.27

u/l

0.70

438

2319

(3003458) Phosphate [Moles/volume] in Serum or Plasma

493

2707

1.97

38.00

5.4

4.7

1.07

1.00

mmol/l

4.43

446

2499

(3009542) Hematocrit [Volume Fraction] of Blood

2938

26769

2.64

37.77

30.1

19.0

40.01

40.11

0.18

2795

24700

(3044889) 12 lead EKG panel

2097

17193

1.67

37.68

5.7

3.2

—

(3035941) MCH [Entitic mass]

2939

26795

2.63

37.50

29.8

18.9

30.42

30.43

0.04

2900

26226

(3024731) MCV [Entitic volume]

2939

26795

2.63

37.50

29.8

18.9

91.71

91.41

3.28

2900

26228

(3010813) Leukocytes [#/volume] in Blood

2939

26795

2.63

37.50

29.9

19.0

6.97

6.69

e9/l

6.95

2857

25729

(3026361) Erythrocytes [#/volume] in Blood

2939

26797

2.63

37.46

29.9

19.0

4.43

4.47

e12/l

4.09

2856

25737

(3026493) Urate [Moles/volume] in Serum or Plasma

905

6011

1.71

37.37

3.0

2.5

3818.25

5664.20

umol/l

0.63

742

5152

(3007461) Platelets [#/volume] in Blood

2938

26790

2.62

37.32

29.9

19.0

239.28

248.95

e9/l

12.27

2866

25841

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

291

1311

2.34

37.30

1.9

1.6

—

(3000963) Hemoglobin [Mass/volume] in Blood

2939

26806

2.63

37.27

30.2

19.1

133.70

135.12

g/l

5.85

2900

26240

(3022313) Gas panel - Capillary blood

236

969

2.55

37.05

4.3

2.9

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

227

922

2.58

36.44

1.5

1.55

1.60

g/l

0.29

188

781

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

439

2347

2.01

36.41

6.7

6.1

4.99

5.10

kpa

1.41

428

2238

(3027801) Oxygen [Partial pressure] in Arterial blood

439

2348

2.01

36.36

6.7

6.1

11.80

12.71

kpa

2.78

425

2239

(3037467) Urinalysis macro (dipstick) panel - Urine

2049

16784

1.64

36.11

4.9

4.2

—

(3003396) Base excess in Arterial blood by calculation

436

2335

2.01

35.96

6.7

6.1

0.31

0.98

mmol/l

2.54

382

1826

(3024561) Albumin [Mass/volume] in Serum or Plasma

1413

10631

1.60

35.05

4.4

34.94

35.40

g/l

2.27

1310

9740

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

438

2379

1.98

34.62

1.8

1.6

—

(3000991) Gas panel - Venous blood

336

1657

2.15

34.51

9.0

6.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

210

846

2.59

34.25

4.8

3.0

24.81

24.78

mmol/l

0.03

188

764

(3021960) Folate [Moles/volume] in Serum or Plasma

886

5993

1.67

33.49

1.6

1.5

20.35

20.93

nmol/l

0.52

730

4996

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1798

14443

1.58

32.77

3.3

3.0

52.65

50.81

u/l

0.39

1642

13127

(3019225) pH of Specimen

472

2678

1.90

32.65

4.5

4.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

427

2372

1.93

31.41

1.8

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

359

1882

2.03

31.21

2.2

2.3

69.59

65.99

e9/l

1.16

287

1419

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

210

890

2.46

30.75

1.9

1.6

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

220

954

2.40

30.63

2.1

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

343

1781

2.04

30.59

8.1

5.6

1.35

1.30

mmol/l

0.37

333

1732

(3033658) Prothrombin time (PT) actual/Normal

863

5960

1.62

29.34

4.0

3.5

82.52

93.80

24.98

847

5823

(3018095) Leukocytes [#/volume] in Urine

1152

8524

1.56

29.07

4.3

3.5

144.62

109.71

e6/l

0.25

836

6008

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1429

11106

1.53

28.68

2.7

2.5

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

233

1094

2.22

26.90

3.1

4.37

4.48

pmol/l

0.53

205

958

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

259

1272

2.13

26.70

8.9

7.5

0.63

0.70

2.30

259

1261

(3002582) Erythrocytes [#/volume] in Urine

1012

7382

1.55

26.68

3.8

3.1

82.00

85.35

e6/l

0.05

793

5615

(3020682) Albumin/Creatinine [Ratio] in Urine

1092

8105

1.53

26.57

4.2

3.7

10.06

5.67

mg/mmol

1.71

655

4988

(3014007) Fractional oxyhemoglobin in Arterial blood

259

1280

2.12

26.26

8.9

7.5

93.79

94.43

0.82

259

1274

(3018418) pH of Serum or Plasma

998

7285

1.54

26.10

3.8

3.6

7.40

0.53

225

1314

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1503

11997

1.49

25.39

2.6

2.4

—

(3012516) Albumin [Mass/volume] in Urine

1036

7675

1.52

25.08

3.5

3.1

389.30

314.58

mg/l

0.20

645

4725

(3030467) Casts [#/volume] in Urine by Automated count

930

6764

1.53

24.39

3.6

3.0

0.65

0.45

e6/l

1.73

708

5088

(3020630) Protein [Mass/volume] in Serum or Plasma

340

1900

1.89

24.27

1.9

2.6

66.06

66.99

g/l

1.40

294

1697

(3009508) Creatinine [Moles/volume] in Urine

1053

7894

1.50

23.80

3.5

3.1

7.03

7.50

mmol/l

3.41

826

6568

(3019309) Folate [Moles/volume] in Red Blood Cells

717

4947

1.58

23.67

1.8

1.7

1131.76

1137.66

nmol/l

0.06

513

3628

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1271

9907

1.48

23.63

2.3

2.1

78.66

79.83

nmol/l

0.71

1086

8643

(40767503) Oxygen content in Capillary blood by calculation

114

413

2.83

22.88

2.7

2.3

16.37

16.61

0.22

212

(3026008) Bacteria identified in Urine by Culture

1019

7636

1.50

22.87

3.4

3.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

160

686

2.40

22.82

3.3

2.0

366.01

637.72

ug/l

1.16

153

641

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

247

1272

2.02

22.36

1.5

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

987

7412

1.48

21.66

2.8

2.4

61.02

60.57

u/l

0.06

902

6750

(3013290) Carbon dioxide [Partial pressure] in Blood

113

424

2.73

21.24

3.1

3.4

4.74

4.99

kpa

2.75

108

414

(3012501) Base excess in Blood by calculation

113

424

2.73

21.24

3.1

3.3

2.40

2.44

mmol/l

0.05

291

(3027315) Oxygen [Partial pressure] in Blood

113

426

2.71

21.05

3.1

3.3

8.65

8.52

kpa

0.37

108

415

(1616796) Gas panel - Central venous blood

112

425

2.70

20.60

3.1

2.9

—

(36304419) Bacteria [Presence] in Urine

880

6522

1.49

20.37

3.5

2.9

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

322

1883

1.79

19.72

4.3

2.9

5.83

5.76

kpa

0.49

312

1832

(3002032) Base excess in Venous blood by calculation

321

1881

1.79

19.52

4.2

2.9

1.63

1.84

mmol/l

0.44

272

1570

(3009445) Proteinase 3 Ab [Units/volume] in Serum

179

861

2.14

19.42

1.7

1.5

9.21

23.85

u/ml

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

571

3893

1.57

19.40

3.5

2.9

2.37

2.36

e6/l

0.01

325

2113

(3003434) Protein [Mass/volume] in Pleural fluid

216

3.34

19.27

1.3

29.98

37.74

g/l

5.50

203

(40758558) Short blood count panel - Blood

797

5873

1.48

18.72

6.4

6.7

—

(3042936) Bacteria identified in Isolate by Culture

474

3122

1.61

18.59

2.1

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

708

5102

1.50

18.55

2.8

2.4

6.37

5.06

e6/l

1.60

613

4516

(3021589) Normoblasts [#/volume] in Blood

1281

10383

1.40

17.56

12.1

8.5

0.00

e9/l

0.11

1022

8433

(3024928) Oxygen saturation in Venous blood

350

2.71

17.43

4.2

2.2

—

(3010421) pH of Blood

120

511

2.40

17.42

3.1

3.3

7.43

7.42

0.85

111

458

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

177

891

2.05

17.04

4.5

3.1

24.18

24.07

mmol/l

0.16

172

872

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

588

4148

1.51

16.88

3.3

2.7

1.16

1.17

e6/l

0.03

343

2350

(3037522) Nuclear Ab [Titer] in Serum

416

2714

1.61

16.87

1.3

572.92

538.95

titre

0.12

593

(3026782) Osmolality of Urine

680

4945

1.48

16.81

2.9

2.7

518.37

557.75

mosm/kgh2o

5.22

559

4176

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

290

1726

1.75

16.65

3.4

3.2

94.61

82.73

ng/l

1.51

246

1459

(3012441) Differential panel - Pleural fluid

173

3.40

16.28

1.3

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

917

7108

1.41

15.94

2.8

3.2

38.36

36.02

u/l

0.25

850

6685

(3024354) Oxygen [Partial pressure] in Venous blood

264

1551

1.77

15.84

3.6

2.4

4.68

4.45

kpa

0.71

252

1503

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

144

694

2.13

15.58

1.6

85.71

247.73

titre

—

(3051593) INR in Capillary blood by Coagulation assay

4.60

15.39

2.8

4.3

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

483

2.35

15.38

2.3

2.0

129.61

129.65

g/l

0.00

332

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

205

1126

1.88

15.33

10.0

8.0

—

(3004588) Protein electrophoresis panel - Serum or Plasma

272

1629

1.73

15.26

1.7

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

375

2443

1.61

15.22

4.1

3.1

—

(3021901) Oxygen saturation in Capillary blood

359

2.55

15.06

3.0

2.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

1080

8679

1.37

14.90

3.1

3.5

2.35

2.36

mmol/l

1.81

891

7495

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

265

1586

1.73

14.89

1.5

1.6

—

(3019060) Gas panel - Arterial blood

229

1317

1.80

14.77

3.1

4.3

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

4.69

14.46

4.3

1.8

410.94

1369.30

u/ml

2.13

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

166

880

1.94

13.83

2.0

1.8

2.22

2.16

ug/l

0.02

146

769

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

5.04

13.83

3.9

2.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

434

2.30

13.09

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

434

2.30

13.09

1.3

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

530

3878

1.44

12.30

1.5

1.4

2.52

2.55

g/l

0.15

299

2211

(3042631) Mycobacterium sp identified in Specimen

315

2.48

12.28

2.2

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

2247

20460

1.35

12.27

23.3

15.3

15.72

15.13

3.71

2217

20020

(3052851) Hemolysis interference index of Serum or Plasma

127

640

2.03

12.25

3.5

3.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

369

2516

1.53

12.18

2.3

2.6

6.67

9.06

umol/l

2.69

315

2200

(40768797) Stomach Pathology biopsy report

468

3353

1.47

12.12

1.3

1.2

—

(3000492) Spirometry study

306

2006

1.58

12.02

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

197

1152

1.76

12.02

1.3

1.2

264.74

240.20

u/ml

0.09

184

1051

(3028308) Erythrocytes [#/volume] in Pleural fluid

181

2.96

11.98

1.4

1.3

43557.14

94874.05

e6/l

0.76

(3004451) EKG impression Narrative

4.01

11.91

1.1

1.2

—

(4200892) Spirometry reversibility

258

1628

1.64

11.87

1.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

199

2.85

11.80

1.4

1.3

1033.00

2523.19

e6/l

2.46

139

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

331

2219

1.55

11.79

2.1

2.2

0.21

g/l

1.01

300

2077

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

108

521

2.11

11.72

1.6

1.5

1.15

1.19

g/l

0.69

485

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

104

502

2.11

11.29

1.6

1.5

0.22

0.24

g/l

0.88

469

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

139

745

1.91

11.25

2.5

—

(3014271) Vancomycin [Susceptibility]

128

3.23

10.81

3.0

2.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

155

872

1.82

10.79

1.7

2.2

2.94

2.92

g/l

0.09

129

763

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

480

2.10

10.64

2.9

2.3

3.79

3.58

g/l

0.55

458

(3022145) Colonoscopy Study observation

383

2717

1.47

10.36

1.3

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1141

9614

1.29

10.34

5.4

5.3

2.97

3.74

ug/l

0.77

982

8631

(3007853) Bacteria identified in Skin by Aerobe culture

354

2475

1.49

10.31

1.9

1.6

—

(40768804) Tissue Pathology biopsy report

1194

10127

1.29

10.26

2.3

2.2

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

589

4517

1.37

10.26

1.3

1.2

1.93

1.70

u/ml

0.16

143

1147

(3009261) Glucose [Presence] in Urine by Test strip

1372

11854

1.28

10.15

4.1

3.6

0.01

0.00

estimate

0.28

243

2085

(3037121) Protein [Mass/volume] in Urine

137

758

1.84

10.08

3.4

3.2

0.25

0.26

g/l

0.06

286

(3036481) Cortisol [Moles/volume] in Serum or Plasma

280

1873

1.54

10.05

2.3

368.23

372.53

nmol/l

0.12

258

1708

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

928

1.75

9.80

1.7

2.2

7.23

7.51

g/l

1.15

133

817

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

159

928

1.75

9.80

1.7

2.2

—

(3036489) Thrombin time

129

707

1.86

9.79

2.6

1.7

21.35

20.95

0.45

112

628

(3035350) Ketones [Presence] in Urine by Test strip

1351

11693

1.27

9.71

4.1

3.6

0.00

estimate

1.34

267

2313

(3021601) Nitrite [Presence] in Urine by Test strip

1352

11705

1.27

9.68

5.4

4.8

0.00

estimate

0.50

257

2133

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

100

505

2.01

9.66

1.3

1.4

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

158

927

1.74

9.57

1.7

2.2

3.45

3.71

g/l

2.13

132

817

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

111

585

1.93

9.50

1.7

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

103

539

1.94

9.02

2.9

1.9

90.69

91.92

0.21

513

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

487

3700

1.37

8.90

1.3

1.2

32.53

39.32

iu/ml

0.50

122

1160

(3045788) Cell count panel - Pleural fluid

153

2.77

8.54

1.5

1.3

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

146

868

1.72

8.47

1.7

2.2

9.52

10.25

g/l

1.49

121

749

(3015736) pH of Urine

1089

9300

1.26

8.39

3.7

3.3

5.86

5.79

0.24

534

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

612

4857

1.32

8.34

3.0

3.1

2.46

mmol/l

0.10

522

4266

(3025941) Bacteria identified in Stool by Culture

176

1105

1.63

8.30

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

223

2.40

8.08

4.3

2.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

120

685

1.78

8.04

1.7

2.2

0.00

0.06

g/l

1.35

105

628

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

300

2132

1.45

8.01

2.4

38.75

38.60

u/l

0.01

247

1839

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

367

2.07

7.96

2.7

2.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

135

801

1.72

7.91

1.8

2.3

0.54

1.18

g/l

1.53

109

680

(4146454) Self-monitoring of blood glucose

316

2.14

7.83

2.4

2.8

—

(40768806) Pleura Pathology biopsy report

190

2.50

7.81

1.2

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

234

1596

1.50

7.69

1.2

—

(3045414) Leukocytes [Presence] in Urine

170

1084

1.60

7.55

2.2

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

228

1554

1.50

7.52

2.6

2.5

10.26

10.57

g/l

0.46

210

1404

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

121

707

1.74

7.50

2.4

3.1

30.62

54.52

mg/l

1.35

590

(3034860) Kappa light chains.free [Mass/volume] in Serum

121

710

1.73

7.40

2.4

3.1

43.44

118.89

mg/l

0.48

593

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

124

733

1.72

7.38

1.7

2.1

37.07

38.27

g/l

1.33

618

(3011335) Digoxin [Mass/volume] in Serum or Plasma

+∞

7.29

1.7

0.0

—

(3048689) Calprotectin [Mass/mass] in Stool

331

2439

1.40

7.23

1.9

2.2

125.93

158.08

ug/g

1.21

262

1899

(3017143) Hepatitis C virus Ab [Presence] in Serum

263

1861

1.45

7.19

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

100

3.02

7.19

1.2

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

100

3.02

7.19

1.2

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

466

1.89

7.18

1.6

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

108

619

1.77

7.17

1.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

452

3505

1.34

7.16

1.3

1.2

10.01

13.94

u/ml

0.64

142

1280

(3021879) Hepatitis B virus core Ab [Presence] in Serum

182

1197

1.55

7.09

1.4

—

(4034850) Laboratory test

128

774

1.68

7.03

8.9

8.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

108

623

1.76

7.02

1.1

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

184

1216

1.55

7.02

1.9

1.8

1.15

1.42

g/l

1.32

161

1093

(3049717) Cytology report of Urine Cyto stain

162

1047

1.58

6.83

2.8

—

(3000494) Fungus identified in Specimen by Culture

361

2730

1.36

6.73

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

217

2.28

6.71

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

296

2.08

6.68

1.4

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

296

2.08

6.68

1.4

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

424

3295

1.33

6.60

6.5

5.9

—

(3003181) Sodium [Moles/volume] in Urine

408

1.91

6.60

1.3

58.27

63.02

mmol/l

0.52

325

(3008152) Bicarbonate [Moles/volume] in Arterial blood

190

1283

1.51

6.58

4.9

6.0

24.78

24.67

mmol/l

0.15

185

1217

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

683

5654

1.27

6.58

3.3

3.2

0.81

ug/l

0.01

491

3949

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

459

1.85

6.55

1.4

1.7

2.36

4.58

iu/l

3.36

152

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

481

1.83

6.54

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

164

2.46

6.51

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

105

617

1.73

6.43

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

294

2.06

6.41

1.4

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

343

1.97

6.36

1.7

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

302

2.04

6.35

1.4

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

276

2018

1.40

6.31

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

296

2.05

6.31

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

107

637

1.70

6.26

1.8

2.2

0.00

g/l

0.50

583

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

345

1.96

6.26

1.7

1.8

21.57

27.07

mg/l

0.32

(3020891) Body temperature

129

808

1.62

6.22

3.6

3.9

—

(3045424) Erythrocytes [Presence] in Urine

431

1.85

6.21

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

127

2.62

6.13

1.4

13.21

11.72

u/l

0.76

121

(3025468) Yersinia sp identified in Specimen by Organism specific culture

294

2.03

6.05

1.4

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

152

2.45

6.02

1.2

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

473

1.80

5.98

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

282

2090

1.38

5.96

4.2

3.4

1.22

1.23

mmol/l

2.14

258

1781

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

124

779

1.62

5.92

1.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

3.47

5.72

1.2

1.3

82.23

60.17

2.49

(3018405) Lactate [Moles/volume] in Arterial blood

114

709

1.63

5.68

3.0

3.5

1.34

1.32

mmol/l

0.05

114

701

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

393

1.85

5.68

1.5

1.7

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

267

2.04

5.68

1.3

1.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

260

1919

1.39

5.64

3.9

4.0

0.08

0.12

0.53

573

(3004616) Nuclear Ab [Presence] in Serum

282

2.00

5.61

1.3

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

103

627

1.66

5.59

1.8

2.3

0.00

g/l

-0.00

581

(3017732) Neutrophils [#/volume] in Blood

223

1606

1.42

5.58

3.1

3.3

4.38

5.60

e9/l

1.28

156

1215

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

270

2.02

5.52

1.6

1.5

59.47

55.47

0.29

163

(3010838) Calcium [Moles/time] in 24 hour Urine

400

1.82

5.39

1.8

2.0

5.24

5.10

mmol/24h

0.14

339

(3017181) Myelocytes/100 leukocytes in Blood

269

2015

1.37

5.34

3.9

0.84

0.96

0.41

107

664

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

551

1.69

5.32

1.3

1.2

41.46

40.82

u/ml

—

(3040151) Glucose [Moles/volume] in Capillary blood

233

2.08

5.32

17.7

5.2

7.85

7.51

mmol/l

0.34

182

(3037756) Immunofixation for Serum or Plasma

469

1.75

5.29

1.4

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

776

6659

1.22

5.24

1.6

1.45

1.36

mmol/l

1.63

629

5565

(3025159) Blasts/100 leukocytes in Blood

245

1814

1.38

5.23

4.0

0.02

0.40

1.03

467

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

450

1.75

5.17

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

105

659

1.61

5.09

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

247

1841

1.37

5.07

3.8

0.86

0.74

0.17

568

(46235355) HIV 1 and 2 tests - Meaningful Use set

301

2315

1.33

5.03

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

1.96

5.02

1.3

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

515

1.69

5.00

1.3

1.2

6.91

2.21

u/ml

0.86

(3019977) pH of Arterial blood

111

2.54

4.95

1.6

2.4

7.42

0.07

(3007566) Smooth muscle Ab [Titer] in Serum

543

1.66

4.84

1.1

1.2

255.00

91.25

titre

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

520

1.67

4.84

1.3

1.2

3.15

6.66

u/ml

0.89

(3017569) Oxygen content in Arterial blood

101

2.59

4.80

2.0

2.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

110

709

1.57

4.79

1.6

1.4

248.73

275.06

ug/g

0.80

410

(40768443) Skin Pathology biopsy report

157

1092

1.46

4.78

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

139

2.32

4.68

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

404

1.75

4.67

1.5

2.8

30.81

37.61

umol/l

1.19

362

(3021788) Differential panel - Synovial fluid

397

1.75

4.65

1.4

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

503

1.67

4.64

2.3

3.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

103

2.54

4.62

1.8

2.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

651

5552

1.22

4.62

3.7

3.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

303

1.86

4.61

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

135

2.31

4.52

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

655

5604

1.21

4.49

1.8

1.7

24854828.31

26909198.46

pmol/l

0.04

515

4571

(3000012) Reticulocyte production index

306

1.85

4.48

1.6

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

628

1.58

4.40

3.1

2.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

2.51

4.37

2.6

2.3

—

(36660697) Celiac disease serology panel - Serum

213

1591

1.36

4.35

1.1

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

170

2.13

4.34

1.1

—

(3002256) Pathology report gross observation

415

3397

1.26

4.31

1.4

1.3

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

173

1251

1.41

4.29

1.1

1.2

87.02

140.32

iu/ml

1.66

433

(3008757) Leukocyte morphology finding [Identifier] in Blood

275

1.87

4.27

4.7

4.0

—

(3043409) Potassium [Moles/volume] in Arterial blood

603

1.58

4.22

3.2

3.6

3.96

3.83

mmol/l

1.33

598

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

243

1863

1.33

4.18

3.1

2.5

59.50

66.03

ml/min/173m2

2.25

112

706

(3004716) Salmonella sp identified in Stool by Organism specific culture

129

892

1.47

4.09

1.2

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

339

1.75

4.04

1.1

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

377

1.71

4.02

1.2

1.4

11.48

11.34

u/l

0.03

310

(3011648) Oxygen content in Venous blood

136

2.22

4.02

2.4

1.8

10.38

10.63

0.12

136

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

340

1.75

4.00

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

727

6352

1.19

3.92

4.4

3.9

0.00

estimate

0.88

237

2081

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

434

1.65

3.90

1.2

1.60

6.07

u/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

299

1.79

3.87

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

139

986

1.43

3.87

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

187

1.99

3.77

3.2

2.9

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.74

3.75

15.9

1.2

54.92

70.98

mg/l

0.95

(40761536) Microorganisms panel - Urine sediment

249

1947

1.30

3.75

4.7

3.8

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

494

1.59

3.73

1.4

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

186

1397

1.35

3.70

1.3

58.67

67.17

au/ml

—

(3000093) Morphology [Interpretation] in Blood Narrative

203

1.93

3.67

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

616

1.53

3.67

1.4

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

142

2.12

3.64

1.4

—

(3017704) Immunofixation for Urine

116

2.25

3.64

1.1

1.6

—

(3051651) Icteric interference index of Serum or Plasma

117

2.23

3.57

5.8

3.2

—

(40761535) Cells panel - Urine sediment

259

2050

1.29

3.57

3.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

158

2.04

3.50

1.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

456

1.59

3.47

1.3

1.2

—

7.01

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

325

1.70

3.46

1.1

1.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

201

1550

1.32

3.37

2.4

26.74

21.13

au/ml

0.24

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

336

2765

1.24

3.35

1.4

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

614

1.50

3.32

1.5

1.6

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.93

3.29

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

560

1.51

3.25

1.5

1.6

27531.47

11652.31

e6/l

1.26

392

(3044927) Protein electrophoresis panel - Urine

234

1.81

3.25

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

386

1.62

3.23

4.1

3.6

1.68

1.49

0.16

326

(3003327) Ova and parasites identified in Stool by Light microscopy

611

1.49

3.20

1.7

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

157

1.98

3.19

3.8

2.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

130

2.09

3.17

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

460

1.56

3.14

1.7

1.8

1.20

0.76

nmol/l

3.23

387

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

269

1.72

3.05

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

243

1.74

2.90

1.0

1.66

1.77

u/ml

0.08

(3028433) Virus identified in Specimen by Culture

2.38

2.89

1.1

—

(3023419) Bacteria identified in Sputum by Culture

320

1.64

2.87

2.2

2.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

172

1.87

2.81

1.7

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

172

1.87

2.81

1.7

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

172

1.87

2.81

1.7

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

130

2.01

2.80

1.7

2.19

1.96

u/field

0.10

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

130

2.01

2.80

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

194

1.81

2.79

1.1

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

2.47

2.78

1.6

2.3

20.63

30.64

2.66

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

300

1.64

2.77

1.3

1.5

115.75

115.40

u/ml

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

172

1340

1.30

2.73

2.6

2.4

—

(3003338) MCHC [Mass/volume]

2063

19752

1.13

2.69

25.3

16.9

331.26

332.28

g/l

5.62

2050

19560

(3035880) pH of Pleural fluid

2.18

2.67

1.3

1.2

—

(3042733) HLA Ab [Presence] in Serum

2.80

2.64

5.0

4.6

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

121

901

1.36

2.64

3.3

4.5

0.85

0.88

0.43

116

847

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

184

1.80

2.60

2.5

2.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

2.60

0.0

1.8

—

2.63

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.01

2.56

1.3

1.1

93.88

106.05

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

106

777

1.38

2.56

1.3

1.2

0.13

1.14

u/ml

1.85

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

261

1.66

2.54

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

526

1.46

2.53

2.7

1.82

1.46

mg/l

3.22

481

(3009871) Measles virus Ab [Titer] in Serum

2.51

2.53

1.4

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

3.23

2.51

1.0

—

(3006462) Nitrate [Presence] in Urine

122

1.97

2.50

3.0

3.7

—

(3022621) pH of Urine by Test strip

201

1618

1.26

2.49

3.0

3.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

454

1.49

2.48

1.1

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

158

1.84

2.47

2.2

2.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

102

2.07

2.47

1.2

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

195

1.75

2.46

1.2

1.6

16.00

24.94

u/ml

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

529

1.45

2.46

1.7

1.8

45.51

42.96

nmol/l

0.26

516

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

210

1.72

2.46

1.8

374.49

1937.11

u/l

1.07

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

854

7796

1.13

2.43

4.6

22.17

21.77

0.33

435

4128

(3048929) Epstein Barr virus Ab [Presence] in Serum

457

1.48

2.41

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

110

2.01

2.40

1.9

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

110

2.01

2.40

1.9

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

361

1.53

2.38

1.2

28.80

27.40

u/l

0.05

303

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

617

1.40

2.37

1.3

1.2

—

(3034426) Prothrombin time (PT)

2.51

2.35

1.5

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

307

1.57

2.33

1.7

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

307

1.57

2.33

1.7

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

697

1.37

2.31

4.3

1.5

4.16

3.92

mg/l

0.06

500

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.46

2.27

1.7

1.2

0.27

0.30

g/l

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

341

1.53

2.27

1.3

1.4

—

(3014891) Appearance of Pleural fluid

4.62

2.27

1.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

271

1.59

2.23

1.3

1.1

114.34

120.16

0.53

240

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.10

2.22

1.1

1.2

—

(44813793) Dust mix specific IgE antibody measurement

128

1.88

2.21

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

256

1.61

2.21

1.3

—

nmol/l

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.34

2.18

2.0

2.2

0.63

0.50

u/field

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

234

1.63

2.16

3.3

3.8

—

(3047181) Lactate [Moles/volume] in Blood

654

1.37

2.16

3.5

5.4

1.45

1.29

mmol/l

0.53

578

(3020876) Protein [Mass/time] in 24 hour Urine

227

1.64

2.14

2.4

2.2

1.11

1.28

g/24h

0.15

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

322

1.53

2.14

1.6

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

2.45

2.10

1.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

153

1.77

2.07

1.1

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.98

2.05

1.1

1.2

1.10

1.05

ratio

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

139

1.80

2.04

2.1

2.2

17.88

15.62

0.48

133

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

215

1.63

2.03

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

270

1.56

2.03

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

367

1.48

2.03

1.3

1.2

40.53

35.41

u/ml

—

(21494434) Karyotype in Bone marrow

200

1.66

2.01

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

336

1.50

1.99

1.2

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

148

1.76

1.98

1.2

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

304

1.52

1.98

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

141

1.78

1.96

2.2

70.32

71.19

0.11

133

(3003694) ABO and Rh group [Type] in Blood

675

6150

1.12

1.95

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

305

1.52

1.95

1.5

0.81

0.89

g/l

0.21

231

(3011985) Renin [Units/volume] in Plasma

290

1.52

1.92

1.5

1.4

102.54

58.18

mu/l

0.33

261

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

364

1.46

1.91

1.4

1.3

160.00

219.43

miu/ml

0.52

144

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.25

1.90

2.2

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

340

1.48

1.89

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

415

1.43

1.88

1.4

1.7

321.17

312.04

mu/l

0.07

387

(3024932) HLA-DR beta [Type]

2.31

1.87

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

136

1.77

1.87

2.5

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

267

2285

1.18

1.87

1.6

1.5

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

526

1.38

1.86

1.1

0.80

5.07

u/ml

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

351

1.46

1.83

1.2

1.4

—

9.43

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

214

1.60

1.82

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

2.13

1.81

1.5

2.3

11.93

11.04

0.09

(3024471) HLA-A [Type]

2.27

1.80

1.0

—

(3041096) Erythrocytes [Presence] in Urine by Automated

674

6170

1.12

1.80

4.2

3.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.96

1.79

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

504

1.38

1.79

1.4

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.76

1.79

1.6

1.2

—

(3044941) Cell count panel - Synovial fluid

354

1.45

1.76

1.2

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

139

1.73

1.75

2.0

1.8

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.92

1.72

2.0

2.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

291

1.48

1.69

1.3

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

579

1.34

1.68

2.4

2.2

212.83

84.16

ug/min

0.79

337

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

308

1.47

1.68

1.2

265.57

269.07

u/ml

0.03

182

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

485

1.37

1.67

1.2

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

149

1.68

1.66

1.8

1.5

83.60

82.70

umol/l

0.05

149

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.80

1.65

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

590

1.33

1.64

2.9

3.4

31.59

884.80

u/ml

1.27

541

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

336

2962

1.15

1.64

3.8

4.3

5.72

27.43

ug/l

4.05

266

2441

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

958

8976

1.10

1.61

4.5

3.8

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

412

1.39

1.60

4.1

3.4

60.47

57.73

0.79

412

(3047007) Chlamydophila sp Ab [Presence] in Serum

254

1.50

1.60

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.50

1.59

4.9

5.9

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.50

1.59

1.5

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

279

1.48

1.59

1.3

1.2

3.86

3.38

u/ml

0.14

112

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

106

1.80

1.58

3.2

3.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.70

1.58

1.0

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

175

1.61

1.57

1.4

1.3

26.99

34.35

u/l

0.66

141

(3010144) Erythrocytes [#/volume] in Synovial fluid

223

1.53

1.56

1.5

1.3

25671.91

101067.48

e6/l

0.98

152

(3016650) Hepatitis A virus Ab [Presence] in Serum

297

1.45

1.55

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

322

1.43

1.55

1.0

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

289

1.46

1.55

1.3

1.2

9.36

1.95

u/ml

0.68

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.49

1.6

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.07

1.49

1.6

2.0

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.23

1.46

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

310

1.43

1.45

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.50

1.45

1.9

2.1

16.21

20.59

umol/l

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.50

1.45

1.1

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

212

1.51

1.43

1.7

2.0

1.87

2.22

u/field

0.12

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.31

1.43

1.1

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.25

1.40

1.1

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

128

1544

0.82

1.39

1.9

1.8

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.42

1.39

5.0

5.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

398

1.36

1.39

1.2

1.7

—

(3005570) Glucose [Moles/volume] in Urine

239

1.47

1.37

2.4

1.8

—

(3047189) Immunofixation for 24 hour Urine

104

1.73

1.36

1.8

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.34

0.0

4.4

—

44.62

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.87

1.34

26.2

23.3

90.00

112.31

ug/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

299

1.41

1.33

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

266

1.43

1.32

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

258

1.44

1.31

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

255

2245

1.15

1.31

1.6

1.7

1.61

1.53

0.27

215

1946

(3045683) HLA typing for celiac disease panel - Blood or Tissue

106

1.70

1.29

1.1

1.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.78

1.28

1.0

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.09

1.27

1.2

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.00

1.27

1.1

—

(3020491) Glucose [Moles/volume] in Blood

178

1.52

1.26

1.2

1.9

7.29

6.66

mmol/l

0.75

118

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

113

932

1.22

1.25

1.4

1.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

180

1.50

1.20

1.4

1.3

6.69

6.45

g/l

0.12

125

(3028192) IgG subclass 2 [Mass/volume] in Serum

180

1.50

1.20

1.4

1.3

3.11

3.08

g/l

0.02

124

(3024139) IgG subclass 3 [Mass/volume] in Serum

180

1.50

1.20

1.4

1.3

0.39

0.38

g/l

0.03

124

(3044290) Cell count panel - Cerebral spinal fluid

480

1.30

1.18

1.3

1.4

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.88

1.18

1.1

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

265

1.40

1.16

1.4

1.3

247.39

278.82

pmol/l

0.33

229

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.00

1.16

5.1

2.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.00

1.16

2.5

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.50

1.15

1.4

1.5

46.00

49.55

umol/l

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.73

1.15

1.2

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

1.73

1.15

1.0

1.3

139.67

166.33

mmol/24h

0.79

(3019150) Specific gravity of Urine by Refractometry

552

5128

1.09

1.12

4.5

4.0

1.02

kg/l

0.01

816

(4062490) Immunoglobulin typing, IgG

176

1.48

1.10

1.5

1.3

—

(3012565) Volume of 24 hour Urine

1.67

1.10

2.5

2.6

1951.25

1832.10

0.20

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

320

1.35

1.09

1.2

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

312

1.35

1.08

5.6

4.7

363.38

348.54

umol/l

0.22

276

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

2.12

1.05

1.0

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.67

1.04

1.4

1.3

22.42

29.79

umol/l

0.50

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.27

1.03

6.6

6.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.84

1.02

1.0

1.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

609

1.24

1.01

1.6

0.53

5.05

iu/ml

0.45

126

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

100

837

1.20

1.00

1.4

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

205

1.42

1.00

1.6

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.65

1.00

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.88

1.00

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

198

1753

1.14

0.99

2.2

2.1

11.24

12.48

nmol/l

1.03

176

1546

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.18

0.98

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.18

0.98

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.18

0.98

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.18

0.98

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.95

0.97

1.1

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.80

0.96

2.3

1.5

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.89

0.94

3.3

1.4

88.89

168.81

ng/l

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.89

0.94

1.1

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

277

1.34

0.93

1.1

—

11.68

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

117

1.54

0.93

1.3

1.4

1.56

1.59

g/l

0.19

117

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.73

0.92

1.0

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

193

1.40

0.90

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

1.75

0.90

2.2

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

102

0.49

0.89

1.6

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

297

1.32

0.89

2.6

1.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

726

0.81

0.87

5.1

4.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

229

1.36

0.86

1.1

1.0

2.44

3.73

u/ml

0.48

106

(3000034) Microalbumin [Mass/volume] in Urine

238

1.35

0.86

4.6

3.1

146.19

30.22

mg/l

0.87

177

(3036180) Methadone [Presence] in Urine

1.82

0.85

1.0

1.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

204

1.38

0.85

2.0

1.4

—

(3025130) Human papilloma virus identified in Specimen

204

1.38

0.85

1.7

1.8

—

(3022689) Creatine [Moles/volume] in Urine

1.69

0.82

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

215

1.35

0.80

1.7

1.5

34.34

30.73

0.17

121

(3029075) Extractable nuclear Ab panel - Serum

1.67

0.78

1.1

1.0

—

(3036603) Volume of Urine

156

1.41

0.78

1.3

1.6

1583.41

1826.66

0.94

151

(21494755) Public health laboratory ask at order entry panel

126

1435

0.87

0.78

1.3

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.67

0.78

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

131

1.45

0.78

2.0

1.3

1.77

1.14

nmol/l

0.79

(3008401) Mugwort IgE Ab [Units/volume] in Serum

225

1.34

0.78

1.1

1.0

0.67

1.40

u/ml

0.49

(3008898) HLA-B27 [Presence]

584

1.20

0.77

1.0

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

0.50

0.77

2.0

1.3

23.20

29.64

umol/l

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

217

1.34

0.76

1.5

1.3

1.58

1.40

nmol/l

0.46

192

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

115

1.48

0.76

1.2

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.77

0.76

1.0

1.1

—

(4035726) Immunohistochemistry procedure

261

2392

1.10

0.76

1.4

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

149

1.41

0.75

1.0

1.3

0.16

1.28

u/ml

1.08

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

185

0.65

0.75

4.1

5.2

184.10

45.99

u/ml

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.64

0.75

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

124

1.45

0.75

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

124

1.45

0.75

1.1

1.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

227

1.32

0.74

1.2

—

20.29

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

116

1.47

0.74

1.9

2.6

45.11

38.54

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.84

0.73

1.1

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

133

1.43

0.73

1.9

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

108

1.48

0.73

1.6

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.00

0.72

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.00

0.72

1.0

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

176

1.37

0.72

2.2

1.4

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.92

0.70

2.2

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

803

0.84

0.69

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

221

1.32

0.69

2.0

1.4

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.85

0.68

1.0

1.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

1.56

0.68

1.7

2.6

86.42

100.53

1.08

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.64

0.68

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

111

1.44

0.65

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

128

1.41

0.65

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

250

1.28

0.65

1.3

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.59

0.65

1.6

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.57

0.65

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.57

0.65

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.61

0.65

1.2

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.61

0.65

1.2

1.6

122.30

232.21

nmol/24h

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

198

1.32

0.64

1.5

1.4

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

198

1.32

0.64

1.5

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.55

0.62

1.3

2.8

—

(40768800) Prostate Pathology biopsy report

684

0.84

0.61

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1003

0.87

0.60

1.4

1.5

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

122

1.40

0.60

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.54

0.59

1.3

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

192

1.30

0.59

1.3

1.2

2.02

2.01

mmol/l

0.03

180

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

1.38

0.59

1.0

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

131

1.38

0.59

1.0

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.48

0.57

1.0

1.2

—

(3000330) Specific gravity of Urine by Test strip

146

1325

1.11

0.56

3.9

3.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.46

0.56

1.5

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.46

0.56

1.1

1.6

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

230

1.26

0.55

1.4

1.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.58

0.54

1.3

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.58

0.54

1.0

1.1

—

174.00

—

(40768446) Kidney Pathology biopsy report

1.50

0.54

1.2

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

377

1.20

0.53

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

1.54

0.53

1.0

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

108

1.39

0.53

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

100

1.40

0.51

1.1

1.3

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

100

1.40

0.51

1.1

1.3

—

(3013637) Mi-2 Ab [Presence] in Serum

1.41

0.51

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.41

0.51

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.41

0.51

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.41

0.51

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

109

1.38

0.50

1.7

1.6

—

(40757373) Influenza virus identified in Isolate

1.56

0.49

1.1

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.40

0.48

2.4

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.40

0.48

2.4

1.5

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.40

0.48

2.4

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

559

0.86

0.47

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

111

1.35

0.46

1.7

1.4

2.40

3.88

—

(3038515) Glucose [Moles/volume] in Venous blood

523

1.15

0.46

3.9

2.5

7.87

7.61

mmol/l

0.30

512

(3008037) Lactate [Moles/volume] in Venous blood

542

1.15

0.46

3.8

2.5

1.51

1.59

mmol/l

0.36

530

(21494814) CD8 cells/100 lymphocytes in Specimen

1.43

0.45

2.9

2.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

147

1.29

0.45

2.2

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

152

0.72

0.44

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

184

1.25

0.43

1.0

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

175

1.26

0.43

1.1

1.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

499

1.14

0.42

1.3

1.4

38.72

34.41

iu/l

0.45

424

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

151

0.73

0.42

1.2

8.80

9.29

mmol/l

0.19

142

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.43

0.42

1.3

1.7

7.39

8.88

ug/l

—

(3044007) Cell count panel - Peritoneal fluid

1.43

0.42

1.3

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.63

0.42

1.7

1.5

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.63

0.42

1.2

1.0

—

(1002224) Polysomnography panel

727

1.12

0.42

1.0

1.1

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

7.9

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

4.4

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.00

0.41

0.0

1.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

6.37

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.38

0.38

1.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.31

0.37

1.0

1.1

131.20

219.26

iu/ml

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.39

0.36

1.0

1.2

—

(3005033) Fetal Nuchal fold Thickness US

0.64

0.35

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.64

0.35

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

459

0.87

0.35

4.5

4.1

19.42

40.22

u/ml

2.51

449

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.62

0.35

1.4

1.5

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

108

1.30

0.35

1.3

5.95

6.28

mmol/l

0.64

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

108

1.30

0.35

2.0

3.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

122

0.74

0.35

5.0

7.2

—

(3052592) Norovirus Ag [Presence] in Stool

1.40

0.35

1.0

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

795

1.10

0.34

1.2

1.1

—

0.91

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

574

0.89

0.34

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.36

0.34

1.0

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

136

1.25

0.33

1.1

1.4

—

(3024263) Appearance of Synovial fluid

127

1.26

0.33

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.67

0.32

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.67

0.32

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.67

0.32

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.67

0.32

1.5

1.4

—

(40768793) Breast Pathology biopsy report

592

0.89

0.32

1.3

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.71

0.30

12.3

12.7

687.43

845.06

nmol/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

274

2858

0.95

0.30

1.4

—

(3045142) Bone marrow Pathology biopsy report

278

1.15

0.29

1.6

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

148

1.22

0.29

1.3

1.5

161.79

228.81

pmol/l

0.50

148

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

176

1.19

0.28

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

112

1.25

0.28

1.4

1.1

1.10

1.18

u/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

103

1.26

0.28

1.4

1.1

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.25

0.27

3.3

2.1

104.25

152.56

nmol/l

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

117

0.77

0.27

1.0

—

(3048879) Bone marrow aspiration report

1.23

0.27

2.1

1.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.23

0.27

2.9

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

606

1.09

0.26

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.68

0.26

1.0

1.1

2085.00

1753.42

miu/ml

—

(40765096) Chromosome analysis panel by Banding

1.23

0.25

1.3

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

311

1.13

0.25

1.4

1.3

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

1.18

0.24

1.1

1.2

—

25.57

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.32

0.23

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

143

1.19

0.23

1.6

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.19

0.23

1.6

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.19

0.23

1.6

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.28

0.23

3.8

2.8

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

163

1.17

0.21

1.1

1.0

3.28

2.89

u/ml

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.17

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.08

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.21

0.0

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

103

0.78

0.21

1.0

1.2

—

(3002619) Bacteria identified in Specimen by Culture

1.16

0.21

1.2

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.16

0.21

1.6

1.0

15.78

16.72

umol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

126

1.19

0.21

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

145

1.17

0.20

1.1

1.0

0.56

0.39

u/ml

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

145

1.17

0.20

1.2

1.1

—

(3024316) Viscosity of Plasma

0.00

0.20

0.0

1.6

—

1.75

—

(1617658) Protocol used for examination of sentinel lymph nodes

229

0.87

0.20

1.2

1.0

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.20

0.19

1.2

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

146

1.17

0.19

1.6

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

146

1.17

0.19

1.6

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

146

1.17

0.19

1.6

1.1

—

(1761868) Lipid panel - Serum or Plasma

786

7743

1.02

0.18

3.5

3.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

195

1.13

0.17

1.1

1.0

0.66

1.43

u/ml

0.59

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

0.73

0.17

1.4

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

263

1.10

0.16

1.2

1.1

1.57

1.50

u/ml

0.02

139

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

515

0.93

0.16

1.5

227.38

877.62

e6/l

1.44

414

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

515

0.93

0.16

1.4

13.26

17.05

e6/l

0.14

395

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.14

0.16

1.1

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

0.77

0.15

1.8

1.4

1.80

2.12

umol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

120

1246

0.96

0.14

1.3

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.19

0.14

1.4

1.8

—

110311.08

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

122

1.15

0.13

1.6

1.8

—

(40768441) Liver Pathology biopsy report

159

0.88

0.13

1.2

1.3

—

(3006653) Thiamine [Moles/volume] in Blood

107

0.84

0.13

1.4

1.2

138.68

140.38

nmol/l

—

107

(4281824) Cell count and differential, peritoneal fluid

252

0.91

0.12

1.4

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

104

1.15

0.12

1.7

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

239

1.09

0.12

1.9

1.4

—

(3004775) Volume in Urine collected for unspecified duration

191

1.10

0.11

2.2

2.1

690.40

622.33

0.25

116

(3003740) Influenza virus B Ag [Presence] in Specimen

240

0.92

0.11

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

239

0.92

0.10

1.0

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.06

0.09

1.4

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

576

1.04

0.09

6.0

3.2

22.29

27.47

mg/l

0.77

352

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

126

1.11

0.09

1.5

1.6

—

(40768795) Lymph node Pathology biopsy report

247

0.93

0.08

1.0

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.03

0.08

1.0

—

0.20

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

490

1.04

0.07

1.4

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

0.80

0.07

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

225

1.07

0.07

1.2

1.1

—

18.58

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.04

0.07

1.3

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

109

1.10

0.06

1.2

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

119

1168

1.02

0.05

3.2

3.7

46.29

71.18

u/ml

1.08

113

1129

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

238

1.05

0.05

1.2

1.1

—

1.63

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

258

1.05

0.04

1.2

6.89

7.69

mmol/l

0.66

215

(3016879) Cocaine [Presence] in Urine

292

0.96

0.04

1.9

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

312

0.96

0.04

1.9

1.5

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

150

0.93

0.04

1.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

101

1.09

0.04

1.1

1.4

—

(3008295) Osmolality of Serum or Plasma

240

1.04

0.03

1.2

1.4

284.90

279.45

mosm/kgh2o

0.84

177

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

191

1.05

0.03

1.3

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

1.08

0.03

1.0

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

209

0.96

0.03

1.2

1.3

—

(3023410) Appearance of Cerebral spinal fluid

221

1.04

0.03

1.5

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

460

0.98

0.02

2.0

1.6

—

(3019832) Treponema pallidum Ab [Presence] in Serum

800

0.99

0.02

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

999

0.99

0.01

2.3

3.4

243.30

3297.63

u/ml

1.53

857

(3014133) Dog dander IgE Ab [Units/volume] in Serum

177

0.96

0.01

1.2

1.0

2.86

2.46

u/ml

—

(3028300) Cannabinoids [Presence] in Urine

316

0.98

0.00

1.9

1.5

—

(3032773) Endomysium IgG Ab [Titer] in Serum

178

1.01

0.00

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

191

0.99

0.00

2.9

2.1

—

(3027008) Opiates [Presence] in Urine

315

0.98

0.00

1.8

1.5

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

160

1.00

0.00

1.3

1.4

0.80

1.15

promille

—

122

(3027944) Amphetamines [Presence] in Urine

311

1.00

0.00

1.9

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.02

0.00

1.4

1.2

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.0

5.0

—

35.33

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

5.97

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

131.88

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

-0.00

0.0

1.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.25

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

-0.00

0.0

6.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

-0.00

0.0

1.8

—

1.35

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.5

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.91

-0.00

1.0

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

1270.00

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

0.91

-0.00

1.6

1.3

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.0

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.02

-0.00

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

0.96

-0.00

1.2

125.60

102.36

—

Mortality – FinRegistry

↥

Association

Association between endpoint I9_LBBB and mortality.

Females

Parameter	HR [95% CI]	p-value
I9_LBBB	1.485 [1.31, 1.69]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.049

During the follow-up period (1.1.1998 — 31.12.2019), 1404 out of 6319 females with I9_LBBB died.

Males

Parameter	HR [95% CI]	p-value
I9_LBBB	1.602 [1.39, 1.85]	< 0.001
Birth year	0.983 [0.97, 0.99]	< 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 1722 out of 5910 males with I9_LBBB died.

Mortality risk

Mortality risk for people of age

years, who have I9_LBBB.

N-year risk	Females	Males
1	0.122%	0.242%
5	0.711%	1.661%
10	1.908%	4.146%
15	3.579%	8.024%
20	6.132%	13.259%

Relationships between endpoints

↥

Index endpoint: I9_LBBB – Left bundle-branch block

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Left bundle-branch block

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints